CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | azaspiro compound |
|
Accession: | CHEBI:35624
|
browse the term
|
Definition: | An azaspiro compound is a spiro compound in which at least one of the cyclic components is a nitrogen heterocyle. |
Synonyms: | related_synonym: | azaspiro compounds |
|
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
ISO |
13-desmethylspirolide C binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein] |
CTD |
PMID:26063663 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
multiple interactions |
ISO |
13-desmethylspirolide C binds to and results in decreased activity of CHRNA7 protein |
CTD |
PMID:26063663 |
|
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
ISO |
13-desmethylspirolide C binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein] |
CTD |
PMID:26063663 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
increases expression |
ISO |
azaspiracid results in increased expression of ABCG2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Adpgk |
ADP-dependent glucokinase |
increases expression |
ISO |
azaspiracid results in increased expression of ADPGK mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 8:59,699,400...59,727,352
Ensembl chr 8:59,699,388...59,727,351
|
|
G |
Afp |
alpha-fetoprotein |
decreases expression |
ISO |
azaspiracid results in decreased expression of AFP mRNA |
CTD |
PMID:28939011 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Alb |
albumin |
decreases expression |
ISO |
azaspiracid results in decreased expression of ALB mRNA |
CTD |
PMID:28939011 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
decreases expression |
ISO |
azaspiracid results in decreased expression of ARNT mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
B3gnt3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
increases expression |
ISO |
azaspiracid results in increased expression of B3GNT3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr16:18,401,405...18,410,821
Ensembl chr16:18,401,405...18,410,766
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
decreases expression |
ISO |
azaspiracid results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
increases expression |
ISO |
azaspiracid results in increased expression of BHLHE40 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Calu |
calumenin |
increases expression |
ISO |
azaspiracid results in increased expression of CALU mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
azaspiracid results in increased activity of CASP3 protein |
CTD |
PMID:20047973 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cd44 |
CD44 molecule |
increases expression |
ISO |
azaspiracid results in increased expression of CD44 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cdh1 |
cadherin 1 |
increases expression decreases uptake |
ISO |
azaspiracid results in increased expression of CDH1 protein modified form azaspiracid results in decreased uptake of CDH1 protein modified form |
CTD |
PMID:17118960 PMID:20547569 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
increases expression |
ISO |
azaspiracid results in increased expression of CEACAM1 mRNA |
CTD |
PMID:21853993 PMID:28939011 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Ceacam6 |
CEA cell adhesion molecule 6 |
increases expression |
ISO |
azaspiracid results in increased expression of CEACAM6 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 1:80,416,531...80,434,668
Ensembl chr 1:80,416,531...80,434,668
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression |
ISO |
azaspiracid results in increased expression of CEBPB mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Ctsd |
cathepsin D |
decreases metabolic processing |
ISO |
azaspiracid results in decreased metabolism of CTSD protein |
CTD |
PMID:23387425 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
ISO |
azaspiracid results in increased expression of DDIT4 mRNA |
CTD |
PMID:21853993 PMID:28939011 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Defb1 |
defensin beta 1 |
decreases expression |
ISO |
azaspiracid results in decreased expression of DEFB1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
increases expression |
ISO |
azaspiracid results in increased expression of DHCR7 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
affects expression |
ISO |
azaspiracid affects the expression of DNAJC10 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:65,232,031...65,272,732
Ensembl chr 3:65,232,697...65,272,719
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
azaspiracid results in increased expression of DUSP6 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Edaradd |
EDAR associated via death domain |
increases expression |
ISO |
azaspiracid results in increased expression of EDARADD mRNA |
CTD |
PMID:28939011 |
|
NCBI chr17:85,866,629...85,910,612
Ensembl chr17:85,656,905...85,910,447
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
increases expression |
ISO |
azaspiracid results in increased expression of EGLN1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr19:52,867,900...52,907,308
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
increases expression |
ISO |
azaspiracid results in increased expression of EGLN3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
ISO |
azaspiracid results in increased expression of EGR1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression |
ISO |
azaspiracid results in increased expression of EIF2AK3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
increases expression |
ISO |
azaspiracid results in increased expression of ELOVL6 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
ISO |
azaspiracid results in increased expression of EMP1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Eno1 |
enolase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of ENO1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
azaspiracid results in increased expression of ENO2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
decreases expression |
ISO |
azaspiracid results in decreased expression of ERN1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of FDFT1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fdps |
farnesyl diphosphate synthase |
increases expression |
ISO |
azaspiracid results in increased expression of FDPS mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fga |
fibrinogen alpha chain |
decreases expression |
ISO |
azaspiracid results in decreased expression of FGA mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fgb |
fibrinogen beta chain |
decreases expression |
ISO |
azaspiracid results in decreased expression of FGB mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
ISO |
azaspiracid results in decreased expression of FGG mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
azaspiracid results in increased expression of FOS mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gpc5 |
glypican 5 |
decreases expression |
ISO |
azaspiracid results in decreased expression of GPC5 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr15:92,207,275...93,644,054
Ensembl chr15:92,239,176...93,643,282
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
affects expression |
ISO |
azaspiracid affects the expression of GPI mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
decreases expression |
ISO |
azaspiracid results in decreased expression of GSTA1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
decreases expression |
ISO |
azaspiracid results in decreased expression of GSTA2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
decreases expression |
ISO |
azaspiracid results in decreased expression of GSTA5 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
H1f4 |
H1.4 linker histone, cluster member |
decreases expression |
ISO |
azaspiracid results in decreased expression of H1-4 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
decreases expression |
ISO |
azaspiracid results in decreased expression of HIF1A mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hist1h2al1 |
histone cluster 1 H2A family like 1 |
decreases expression |
ISO |
azaspiracid results in decreased expression of H2AC6 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr17:42,707,954...42,708,420
|
|
G |
Hk2 |
hexokinase 2 |
increases expression |
ISO |
azaspiracid results in increased expression of HK2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hkdc1 |
hexokinase domain containing 1 |
increases expression |
ISO |
azaspiracid results in increased expression of HKDC1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr20:30,335,322...30,373,792
Ensembl chr20:30,335,628...30,373,867
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression |
ISO |
azaspiracid results in increased expression of HMGCR mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of HMGCS1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hoxb6 |
homeo box B6 |
increases expression |
ISO |
azaspiracid results in increased expression of HOXB6 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr10:81,258,726...81,267,458
Ensembl chr10:81,265,056...81,267,449
|
|
G |
Hoxb9 |
homeo box B9 |
increases expression |
ISO |
azaspiracid results in increased expression of HOXB9 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr10:81,237,312...81,240,818
Ensembl chr10:81,237,312...81,240,818
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of IDI1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
azaspiracid results in increased expression of JUN mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions |
ISO |
azaspiracid binds to and results in decreased activity of KCNH2 protein |
CTD |
PMID:22856456 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Lama1 |
laminin subunit alpha 1 |
decreases expression |
ISO |
azaspiracid results in decreased expression of LAMA1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 9:107,692,770...107,816,847
Ensembl chr 9:107,692,770...107,817,478
|
|
G |
Ldlr |
low density lipoprotein receptor |
increases expression |
ISO |
azaspiracid results in increased expression of LDLR mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lmnb1 |
lamin B1 |
decreases expression |
ISO |
azaspiracid results in decreased expression of LMNB1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lpin1 |
lipin 1 |
increases expression |
ISO |
azaspiracid results in increased expression of LPIN1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
decreases expression |
ISO |
azaspiracid results in decreased expression of MAP2K3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK8 protein]; Amiloride inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK8 protein]; azaspiracid results in increased phosphorylation of and affects the localization of MAPK8 protein |
CTD |
PMID:19815690 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
ISO |
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK9 protein]; Amiloride inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK9 protein]; azaspiracid results in increased phosphorylation of and affects the localization of MAPK9 protein |
CTD |
PMID:19815690 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of MGST1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
increases expression |
ISO |
azaspiracid results in increased expression of MGST2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of MMP1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
azaspiracid results in increased expression of MT1A mRNA |
CTD |
PMID:28939011 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Mt1-ps3 |
metallothionein 1, pseudogene 3 |
increases expression |
ISO |
azaspiracid results in increased expression of MT1E mRNA |
CTD |
PMID:28939011 |
|
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
ISO |
azaspiracid results in increased expression of MT2A mRNA |
CTD |
PMID:28939011 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
increases expression |
ISO |
azaspiracid results in increased expression of MTHFD2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Mvk |
mevalonate kinase |
increases expression |
ISO |
azaspiracid results in increased expression of MVK mRNA |
CTD |
PMID:28939011 |
|
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
ISO |
azaspiracid results in increased expression of MYC mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Osr2 |
odd-skipped related transciption factor 2 |
decreases expression |
ISO |
azaspiracid results in decreased expression of OSR2 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 7:66,487,841...66,495,003
Ensembl chr 7:66,487,839...66,495,224
|
|
G |
Pdhb |
pyruvate dehydrogenase E1 subunit beta |
increases expression |
ISO |
azaspiracid results in increased expression of PDHB mRNA |
CTD |
PMID:28939011 |
|
NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
|
|
G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
increases expression |
ISO |
azaspiracid results in increased expression of PDIA3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
|
|
G |
Pfkp |
phosphofructokinase, platelet |
increases expression |
ISO |
azaspiracid results in increased expression of PFKP mRNA |
CTD |
PMID:28939011 |
|
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of PGAM1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of PGK1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression |
ISO |
azaspiracid results in increased expression of PPP1R15A mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Prlr |
prolactin receptor |
decreases uptake |
ISO |
azaspiracid results in decreased uptake of PRLR protein |
CTD |
PMID:20547569 |
|
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
|
|
G |
Rps27a |
ribosomal protein S27a |
increases expression |
ISO |
azaspiracid results in increased expression of RPS27A mRNA |
CTD |
PMID:28939011 |
|
NCBI chr14:103,285,734...103,288,011
Ensembl chr14:103,285,734...103,288,011 Ensembl chr 5:103,285,734...103,288,011 Ensembl chr 5:103,285,734...103,288,011
|
|
G |
Scd |
stearoyl-CoA desaturase |
increases expression |
ISO |
azaspiracid results in increased expression of SCD mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Si |
sucrase-isomaltase |
decreases expression |
ISO |
azaspiracid results in decreased expression of SI mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:157,505,893...157,586,228
Ensembl chr 2:157,506,342...157,585,260
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
increases expression |
ISO |
azaspiracid results in increased expression of SLC2A1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
azaspiracid results in increased expression of SLC7A11 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Sptlc3 |
serine palmitoyltransferase, long chain base subunit 3 |
decreases expression |
ISO |
azaspiracid results in decreased expression of SPTLC3 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 3:126,847,878...126,978,010
Ensembl chr 3:126,847,878...126,978,010
|
|
G |
Sptssb |
serine palmitoyltransferase, small subunit B |
decreases expression |
ISO |
azaspiracid results in decreased expression of SPTSSB mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 2:154,133,728...154,162,127
Ensembl chr 2:154,133,733...154,163,120
|
|
G |
Sqle |
squalene epoxidase |
increases expression |
ISO |
azaspiracid results in increased expression of SQLE mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
increases expression |
ISO |
azaspiracid results in increased expression of SREBF1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Stard4 |
StAR-related lipid transfer domain containing 4 |
increases expression |
ISO |
azaspiracid results in increased expression of STARD4 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr18:24,814,683...24,830,024
Ensembl chr18:24,817,107...24,830,024
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
EXP |
azaspiracid results in increased expression of TIMP1 protein |
CTD |
PMID:26865666 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tns4 |
tensin 4 |
increases expression |
ISO |
azaspiracid results in increased expression of TNS4 mRNA |
CTD |
PMID:21853993 |
|
NCBI chr10:84,021,965...84,041,346
Ensembl chr10:84,021,966...84,041,346
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
increases expression |
ISO |
azaspiracid results in increased expression of TPI1 mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
increases expression |
ISO |
azaspiracid results in increased expression of TRIB3 mRNA |
CTD |
PMID:21853993 PMID:28939011 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
increases expression |
ISO |
azaspiracid results in increased expression of TUBB3 mRNA |
CTD |
PMID:21853993 |
|
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
|
|
G |
Ubb |
ubiquitin B |
increases expression |
ISO |
azaspiracid results in increased expression of UBB mRNA |
CTD |
PMID:28939011 |
|
NCBI chr10:47,247,630...47,249,335
Ensembl chr10:47,245,637...47,249,333
|
|
G |
Ubc |
ubiquitin C |
increases expression |
ISO |
azaspiracid results in increased expression of UBC mRNA |
CTD |
PMID:28939011 |
|
NCBI chr12:31,239,149...31,243,924
Ensembl chr12:31,239,152...31,243,925
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
ISO |
azaspiracid results in increased expression of VEGFA mRNA |
CTD |
PMID:28939011 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Abcf1 |
ATP binding cassette subfamily F member 1 |
increases expression |
ISO |
brevianamide A results in increased expression of ABCF1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr20:2,802,519...2,815,433
Ensembl chr20:2,802,488...2,815,433
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
increases expression |
ISO |
brevianamide A results in increased expression of AIMP1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
increases expression |
ISO |
brevianamide A results in increased expression of CCL11 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
|
|
G |
Ccl12 |
C-C motif chemokine ligand 12 |
decreases expression increases expression |
ISO |
brevianamide A results in decreased expression of CCL12 mRNA brevianamide A results in increased expression of CCL12 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
increases expression |
ISO |
brevianamide A results in increased expression of CCL19 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
ISO |
brevianamide A results in decreased expression of CCL2 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
decreases expression increases expression |
ISO |
brevianamide A results in decreased expression of CCL20 mRNA brevianamide A results in increased expression of CCL20 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
increases expression |
ISO |
brevianamide A results in increased expression of CCL24 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
|
|
G |
Ccl25 |
C-C motif chemokine ligand 25 |
increases expression |
ISO |
brevianamide A results in increased expression of CCL25 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr12:2,707,398...2,716,571
Ensembl chr12:2,707,398...2,716,554
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
decreases expression |
ISO |
brevianamide A results in decreased expression of CCL4 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
ISO |
brevianamide A results in increased expression of CCL5 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
decreases expression |
ISO |
brevianamide A results in decreased expression of CCL7 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccr10 |
C-C motif chemokine receptor 10 |
increases expression |
ISO |
brevianamide A results in increased expression of CCR10 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:86,108,551...86,110,988
Ensembl chr10:86,108,551...86,110,988
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
increases expression |
ISO |
brevianamide A results in increased expression of CCR2 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
increases expression |
ISO |
brevianamide A results in increased expression of CCR3 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
|
|
G |
Ccr4 |
C-C motif chemokine receptor 4 |
increases expression |
ISO |
brevianamide A results in increased expression of CCR4 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
increases expression |
ISO |
brevianamide A results in increased expression of CCR6 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
increases expression |
ISO |
brevianamide A results in increased expression of CCR7 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Ccr9 |
C-C motif chemokine receptor 9 |
increases expression |
ISO |
brevianamide A results in increased expression of CCR9 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:123,396,157...123,410,199
Ensembl chr 8:123,395,813...123,413,969
|
|
G |
Cd40lg |
CD40 ligand |
increases expression |
ISO |
brevianamide A results in increased expression of CD40LG mRNA |
CTD |
PMID:19818335 |
|
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
increases expression |
ISO |
brevianamide A results in increased expression of CX3CL1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression |
ISO |
brevianamide A results in increased expression of CXCL12 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl13 |
C-X-C motif chemokine ligand 13 |
increases expression |
ISO |
brevianamide A results in increased expression of CXCL13 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
brevianamide A results in increased expression of CXCL2 protein |
CTD |
PMID:19818335 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
decreases expression |
ISO |
brevianamide A results in decreased expression of CXCL1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
increases expression |
ISO |
brevianamide A results in increased expression of CXCR2 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
increases expression |
ISO |
brevianamide A results in increased expression of CXCR3 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
|
|
G |
Cxcr5 |
C-X-C motif chemokine receptor 5 |
increases expression |
ISO |
brevianamide A results in increased expression of CXCR5 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:44,842,098...44,858,425
Ensembl chr 8:44,843,413...44,857,893
|
|
G |
Il10ra |
interleukin 10 receptor subunit alpha |
increases expression |
ISO |
brevianamide A results in increased expression of IL10RA mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
|
|
G |
Il10rb |
interleukin 10 receptor subunit beta |
increases expression |
ISO |
brevianamide A results in increased expression of IL10RB mRNA |
CTD |
PMID:19818335 |
|
NCBI chr11:30,646,494...30,668,081
Ensembl chr11:30,652,096...30,668,074
|
|
G |
Il11 |
interleukin 11 |
increases expression |
ISO |
brevianamide A results in increased expression of IL11 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
|
|
G |
Il13 |
interleukin 13 |
increases expression |
ISO |
brevianamide A results in increased expression of IL13 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il13ra1 |
interleukin 13 receptor subunit alpha 1 |
increases expression |
ISO |
brevianamide A results in increased expression of IL13RA1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr X:115,348,822...115,408,682
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
|
|
G |
Il16 |
interleukin 16 |
increases expression |
ISO |
brevianamide A results in increased expression of IL16 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
brevianamide A results in increased expression of IL18 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
increases expression |
ISO |
brevianamide A results in increased expression of IL1R1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
increases expression |
ISO |
brevianamide A results in increased expression of IL2RB mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054
|
|
G |
Il2rg |
interleukin 2 receptor subunit gamma |
increases expression |
ISO |
brevianamide A results in increased expression of IL2RG mRNA |
CTD |
PMID:19818335 |
|
NCBI chr X:66,395,330...66,399,026
Ensembl chr X:66,392,542...66,399,823
|
|
G |
Il6r |
interleukin 6 receptor |
increases expression |
ISO |
brevianamide A results in increased expression of IL6RA mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
increases expression |
ISO |
brevianamide A results in increased expression of IL6ST mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
|
|
G |
Ltb |
lymphotoxin beta |
increases expression |
ISO |
brevianamide A results in increased expression of LTB mRNA |
CTD |
PMID:19818335 |
|
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
|
|
G |
Mif |
macrophage migration inhibitory factor |
increases expression |
ISO |
brevianamide A results in increased expression of MIF mRNA |
CTD |
PMID:19818335 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
|
|
G |
Pf4 |
platelet factor 4 |
increases expression |
ISO |
brevianamide A results in increased expression of PF4 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr14:17,298,304...17,299,220
Ensembl chr14:17,298,308...17,299,365
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression |
ISO |
brevianamide A results in increased expression of TGFB1 mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression increases expression |
ISO |
brevianamide A results in decreased expression of TNF mRNA brevianamide A results in increased expression of TNF mRNA; brevianamide A results in increased expression of TNF protein |
CTD |
PMID:19818335 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
increases expression |
ISO |
brevianamide A results in increased expression of TNFRSF1A mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
increases expression |
ISO |
brevianamide A results in increased expression of TNFRSF1B mRNA |
CTD |
PMID:19818335 |
|
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
increases expression |
EXP |
Buspirone results in increased expression of AASS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
EXP |
Buspirone results in increased expression of ABCA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of ABCC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcf1 |
ATP binding cassette subfamily F member 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ABCF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:2,802,519...2,815,433
Ensembl chr20:2,802,488...2,815,433
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of ABCG2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abhd14b |
abhydrolase domain containing 14b |
increases expression |
EXP |
Buspirone results in increased expression of ABHD14B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119
|
|
G |
Abtb1 |
ankyrin repeat and BTB domain containing 1 |
increases expression |
EXP |
Buspirone results in increased expression of ABTB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:121,299,302...121,305,667
Ensembl chr 4:121,299,304...121,305,620
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
increases expression |
EXP |
Buspirone results in increased expression of ACAA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
decreases expression |
EXP |
Buspirone results in decreased expression of ACACA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acbd4 |
acyl-CoA binding domain containing 4 |
increases expression |
EXP |
Buspirone results in increased expression of ACBD4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:88,048,058...88,062,612
Ensembl chr10:88,048,108...88,058,500
|
|
G |
Acly |
ATP citrate lyase |
decreases expression |
EXP |
Buspirone results in decreased expression of ACLY mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Acsf2 |
acyl-CoA synthetase family member 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of ACSF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:79,504,510...79,546,714
Ensembl chr10:79,504,511...79,546,673
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of ACSL3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
increases expression |
EXP |
Buspirone results in increased expression of ACSL4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
decreases expression |
EXP |
Buspirone results in decreased expression of ACSL5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
|
|
G |
Actb |
actin, beta |
decreases expression |
EXP |
Buspirone results in decreased expression of ACTB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actg1 |
actin, gamma 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ACTG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
|
|
G |
Actn1 |
actinin, alpha 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ACTN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Acy1 |
aminoacylase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ACY1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adamtsl4 |
ADAMTS-like 4 |
increases expression |
EXP |
Buspirone results in increased expression of ADAMTSL4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:183,235,634...183,247,091
Ensembl chr 2:183,235,646...183,246,848
|
|
G |
Adcy6 |
adenylate cyclase 6 |
increases expression |
EXP |
Buspirone results in increased expression of ADCY6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:129,742,827...129,763,922
Ensembl chr 7:129,742,838...129,763,754
|
|
G |
Adipor2 |
adiponectin receptor 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
multiple interactions |
EXP |
Buspirone binds to and results in decreased activity of ADRA1A protein |
CTD |
PMID:16545797 |
|
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Adra1d |
adrenoceptor alpha 1D |
multiple interactions |
EXP |
Buspirone binds to and results in increased activity of ADRA1D protein |
CTD |
PMID:15872040 |
|
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
|
|
G |
Agmat |
agmatinase |
increases expression |
EXP |
Buspirone results in increased expression of AGMAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:154,043,665...154,074,278
Ensembl chr 5:154,060,151...154,074,276
|
|
G |
Ahcy |
adenosylhomocysteinase |
increases expression |
EXP |
Buspirone results in increased expression of AHCY mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of AIF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Aig1 |
androgen-induced 1 |
increases expression |
EXP |
Buspirone results in increased expression of AIG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:8,046,430...8,269,276
Ensembl chr 1:8,046,430...8,269,084
|
|
G |
Ak4 |
adenylate kinase 4 |
decreases expression |
EXP |
Buspirone results in decreased expression of AK4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Akap8l |
A-kinase anchoring protein 8 like |
increases expression |
EXP |
Buspirone results in increased expression of AKAP8L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:11,332,671...11,362,287
Ensembl chr 7:11,332,672...11,362,275
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
decreases expression |
EXP |
Buspirone results in decreased expression of AKR7A3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ALDH1B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
|
|
G |
Alkbh7 |
alkB homolog 7 |
increases expression |
EXP |
Buspirone results in increased expression of ALKBH7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:1,838,886...1,841,044
Ensembl chr 9:1,838,811...1,841,044
|
|
G |
Ankh |
ANKH inorganic pyrophosphate transport regulator |
decreases expression |
EXP |
Buspirone results in decreased expression of ANKH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:78,153,027...78,280,181
Ensembl chr 2:78,153,026...78,280,187
|
|
G |
Ankrd46 |
ankyrin repeat domain 46 |
increases expression |
EXP |
Buspirone results in increased expression of ANKRD46 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:67,647,202...67,668,180
Ensembl chr 7:67,647,204...67,668,132
|
|
G |
Antxr2 |
ANTXR cell adhesion molecule 2 |
increases expression |
EXP |
Buspirone results in increased expression of ANTXR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:11,541,718...11,682,110
Ensembl chr14:11,541,772...11,682,094
|
|
G |
Anxa3 |
annexin A3 |
decreases expression |
EXP |
Buspirone results in decreased expression of ANXA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Anxa5 |
annexin A5 |
decreases expression |
EXP |
Buspirone results in decreased expression of ANXA5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Apob |
apolipoprotein B |
decreases expression |
EXP |
Buspirone results in decreased expression of APOB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apol9a-Apol7a |
Apol9a-Apol7a readthrough |
decreases expression |
EXP |
Buspirone results in decreased expression of APOL7B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:109,118,559...109,149,798
Ensembl chr 7:109,131,064...109,147,649
|
|
G |
Apoo |
apolipoprotein O |
decreases expression |
EXP |
Buspirone results in decreased expression of APOO mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:59,157,971...59,262,940
Ensembl chr X:59,158,049...59,262,940
|
|
G |
Apool |
apolipoprotein O-like |
decreases expression |
EXP |
Buspirone results in decreased expression of APOOL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:77,377,723...77,443,672
Ensembl chr X:77,377,781...77,443,900
|
|
G |
App |
amyloid beta precursor protein |
decreases expression |
EXP |
Buspirone results in decreased expression of APP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Arhgap24 |
Rho GTPase activating protein 24 |
decreases expression |
EXP |
Buspirone results in decreased expression of ARHGAP24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:6,800,624...7,183,877
Ensembl chr14:6,800,631...7,183,823
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
decreases expression |
EXP |
Buspirone results in decreased expression of ARHGDIB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
|
|
G |
Arl1 |
ARF like GTPase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ARL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:23,120,004...23,131,173
Ensembl chr 7:23,119,589...23,131,898
|
|
G |
Arl4a |
ARF like GTPase 4A |
increases expression |
EXP |
Buspirone results in increased expression of ARL4A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:57,079,496...57,084,156
Ensembl chr 6:57,078,812...57,085,066
|
|
G |
Arl6ip1 |
ARL6 interacting reticulophagy regulator 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ARL6IP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
|
|
G |
Armt1 |
acidic residue methyltransferase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ARMT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:40,894,558...40,918,302
Ensembl chr 1:40,894,550...40,918,302
|
|
G |
Arsb |
arylsulfatase B |
decreases expression |
EXP |
Buspirone results in decreased expression of ARSB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:25,002,210...25,162,675
Ensembl chr 2:25,002,346...25,162,671
|
|
G |
As3mt |
arsenite methyltransferase |
increases expression |
EXP |
Buspirone results in increased expression of AS3MT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:245,595,939...245,628,921
Ensembl chr 1:245,596,108...245,627,872
|
|
G |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of ASAP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:40,658,201...40,821,017
Ensembl chr 6:40,657,880...40,820,975
|
|
G |
Asgr1 |
asialoglycoprotein receptor 1 |
increases expression |
EXP |
Buspirone results in increased expression of ASGR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:54,775,727...54,779,642
Ensembl chr10:54,776,024...54,779,631
|
|
G |
Aspg |
asparaginase |
increases expression |
EXP |
Buspirone results in increased expression of ASPG mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:131,176,727...131,196,268
Ensembl chr 6:131,176,874...131,196,268
|
|
G |
Atf5 |
activating transcription factor 5 |
increases expression |
EXP |
Buspirone results in increased expression of ATF5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atg2b |
autophagy related 2B |
increases expression |
EXP |
Buspirone results in increased expression of ATG2B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:124,522,283...124,592,412
Ensembl chr 6:124,525,523...124,592,015
|
|
G |
Atl2 |
atlastin GTPase 2 |
increases expression |
EXP |
Buspirone results in increased expression of ATL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:15,139,071...15,180,421
Ensembl chr 6:15,139,044...15,180,421
|
|
G |
Atp11c |
ATPase phospholipid transporting 11C |
increases expression |
EXP |
Buspirone results in increased expression of ATP11C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:138,564,459...138,752,116
Ensembl chr X:138,565,836...138,751,204
|
|
G |
Atp6v0b |
ATPase H+ transporting V0 subunit B |
increases expression |
EXP |
Buspirone results in increased expression of ATP6V0B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:131,423,384...131,424,900
Ensembl chr 5:131,423,387...131,426,401
|
|
G |
Atp6v0e1 |
ATPase H+ transporting V0 subunit e1 |
increases expression |
EXP |
Buspirone results in increased expression of ATP6V0E1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:16,479,656...16,502,732
Ensembl chr10:16,479,567...16,524,434
|
|
G |
Atp6v1g1 |
ATPase H+ transporting V1 subunit G1 |
increases expression |
EXP |
Buspirone results in increased expression of ATP6V1G1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:76,961,462...76,967,642
Ensembl chr 5:76,961,499...76,969,463
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases expression |
EXP |
Buspirone results in decreased expression of AXL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
Azin1 |
antizyme inhibitor 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of AZIN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:69,654,773...69,681,578
Ensembl chr 7:69,654,663...69,681,578
|
|
G |
B4galnt1 |
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
increases expression |
EXP |
Buspirone results in increased expression of B4GALNT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:62,988,429...62,996,190
Ensembl chr 7:62,988,930...62,996,190
|
|
G |
Baiap2l1 |
BAR/IMD domain containing adaptor protein 2 like 1 |
increases expression |
EXP |
Buspirone results in increased expression of BAIAP2L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:10,250,434...10,339,937
Ensembl chr12:10,250,473...10,339,928
|
|
G |
Bgn |
biglycan |
decreases expression |
EXP |
Buspirone results in decreased expression of BGN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
decreases expression |
EXP |
Buspirone results in decreased expression of BHLHE40 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Blvrb |
biliverdin reductase B |
increases expression |
EXP |
Buspirone results in increased expression of BLVRB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
increases expression |
EXP |
Buspirone results in increased expression of BNIP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bola1 |
bolA family member 1 |
increases expression |
EXP |
Buspirone results in increased expression of BOLA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:183,758,515...183,771,445
Ensembl chr 2:183,758,441...183,781,576
|
|
G |
Bpgm |
bisphosphoglycerate mutase |
decreases expression |
EXP |
Buspirone results in decreased expression of BPGM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of BTG2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
C10h17orf58 |
similar to human chromosome 17 open reading frame 58 |
increases expression |
EXP |
Buspirone results in increased expression of C10H17ORF58 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:91,972,938...91,977,606
Ensembl chr10:91,972,410...91,977,602
|
|
G |
C1qb |
complement C1q B chain |
decreases expression |
EXP |
Buspirone results in decreased expression of C1QB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C5h1orf50 |
similar to human chromosome 1 open reading frame 50 |
increases expression |
EXP |
Buspirone results in increased expression of C5H1ORF50 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:132,837,135...132,841,744
Ensembl chr 5:132,836,506...132,841,762
|
|
G |
C5l1 |
complement C5 like 1 |
increases expression |
EXP |
Buspirone results in increased expression of C5L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:18,401,716...18,420,064
Ensembl chr 3:18,404,899...18,420,054
|
|
G |
C6 |
complement C6 |
decreases expression |
EXP |
Buspirone results in decreased expression of C6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
|
|
G |
C8g |
complement C8 gamma chain |
increases expression |
EXP |
Buspirone results in increased expression of C8G mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:8,320,503...8,322,087
Ensembl chr 3:8,305,920...8,323,495
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
decreases expression |
EXP |
Buspirone results in decreased expression of C8H11ORF54 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
|
|
G |
C8h11orf65 |
similar to human chromosome 11 open reading frame 65 |
increases expression |
EXP |
Buspirone results in increased expression of C8H11ORF65 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:53,796,033...53,825,277
Ensembl chr 8:53,796,366...53,824,748
|
|
G |
C8h11orf71 |
similar to human chromosome 11 open reading frame 71 |
increases expression |
EXP |
Buspirone results in increased expression of C8H11ORF71 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:48,838,556...48,838,970
Ensembl chr 8:48,838,100...48,842,270
|
|
G |
C8h15orf61 |
similar to human chromosome 15 open reading frame 61 |
increases expression |
EXP |
Buspirone results in increased expression of C8H15ORF61 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:63,868,125...63,872,863
Ensembl chr 8:63,868,125...63,872,751
|
|
G |
Cald1 |
caldesmon 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of CALD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
|
|
G |
Calm1 |
calmodulin 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of CALM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
|
|
G |
Calm2 |
calmodulin 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of CALM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
|
|
G |
Calr |
calreticulin |
decreases expression |
EXP |
Buspirone results in decreased expression of CALR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of CAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:135,142,108...135,168,885
Ensembl chr 5:135,142,112...135,168,769
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of CAR3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Car5a |
carbonic anhydrase 5A |
increases expression |
EXP |
Buspirone results in increased expression of CAR5A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
EXP |
Buspirone inhibits the reaction [Methotrexate results in increased cleavage of CASP1 protein] |
CTD |
PMID:37341015 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of CASP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
increases expression |
EXP |
Buspirone results in increased expression of CASP6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
decreases expression |
EXP |
Buspirone results in decreased expression of CASP7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Cat |
catalase |
increases expression |
EXP |
Buspirone results in increased expression of CAT protein |
CTD |
PMID:19800952 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbr4 |
carbonyl reductase 4 |
increases expression |
EXP |
Buspirone results in increased expression of CBR4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:28,629,928...28,684,230
Ensembl chr16:28,617,224...28,645,712
|
|
G |
Ccdc6 |
coiled-coil domain containing 6 |
increases expression |
EXP |
Buspirone results in increased expression of CCDC6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:18,432,177...18,528,186
Ensembl chr20:18,433,695...18,528,658
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
decreases expression |
EXP |
Buspirone results in decreased expression of CCDC80 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
decreases expression |
EXP |
Buspirone results in decreased expression of CCL6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
|
|
G |
Ccnb2 |
cyclin B2 |
decreases expression |
EXP |
Buspirone results in decreased expression of CCNB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
EXP |
Buspirone results in decreased expression of CCND1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd164 |
CD164 molecule |
decreases expression |
EXP |
Buspirone results in decreased expression of CD164 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:45,024,051...45,035,628
Ensembl chr20:45,023,973...45,035,634
|
|
G |
Cd5l |
Cd5 molecule-like |
decreases expression |
EXP |
Buspirone results in decreased expression of CD5L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
|
|
G |
Cd68 |
Cd68 molecule |
decreases expression |
EXP |
Buspirone results in decreased expression of CD68 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cd74 |
CD74 molecule |
decreases expression |
EXP |
Buspirone results in decreased expression of CD74 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cdc20 |
cell division cycle 20 |
decreases expression |
EXP |
Buspirone results in decreased expression of CDC20 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of CDK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
decreases expression |
EXP |
Buspirone results in decreased expression of CDKN2C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of CDKN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of CEACAM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Ceacam4 |
CEA cell adhesion molecule 4 |
decreases expression |
EXP |
Buspirone results in decreased expression of CEACAM10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:80,376,667...80,382,943
Ensembl chr 1:80,376,648...80,382,915
|
|
G |
Cep20 |
centrosomal protein 20 |
decreases expression |
EXP |
Buspirone results in decreased expression of CEP20 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:714,051...736,826
Ensembl chr10:714,151...736,837
|
|
G |
Cfl1 |
cofilin 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of CFL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Cgn |
cingulin |
decreases expression |
EXP |
Buspirone results in decreased expression of CGN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:182,308,389...182,335,747
Ensembl chr 2:182,308,714...182,334,645
|
|
G |
Chpt1 |
choline phosphotransferase 1 |
increases expression |
EXP |
Buspirone results in increased expression of CHPT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
|
|
G |
Churc1 |
churchill domain containing 1 |
increases expression |
EXP |
Buspirone results in increased expression of CHURC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:95,464,488...95,485,208
Ensembl chr 6:95,470,683...95,619,586
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of CKS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Clec4f |
C-type lectin domain family 4, member F |
decreases expression |
EXP |
Buspirone results in decreased expression of CLEC4F mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:116,129,023...116,138,744
Ensembl chr 4:116,129,023...116,138,775
|
|
G |
Clic1 |
chloride intracellular channel 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of CLIC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
|
|
G |
Clpb |
ClpB family mitochondrial disaggregase |
decreases expression |
EXP |
Buspirone results in decreased expression of CLPB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:156,028,740...156,158,183
Ensembl chr 1:156,028,930...156,168,788
|
|
G |
Cltb |
clathrin, light chain B |
increases expression |
EXP |
Buspirone results in increased expression of CLTB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:10,001,512...10,019,201
Ensembl chr17:10,001,513...10,019,169
|
|
G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
decreases expression |
EXP |
Buspirone results in decreased expression of CMTM6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:114,422,934...114,441,034
Ensembl chr 8:114,422,921...114,441,033
|
|
G |
Cnppd1 |
cyclin Pas1/PHO80 domain containing 1 |
increases expression |
EXP |
Buspirone results in increased expression of CNPPD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:76,633,475...76,640,164
Ensembl chr 9:76,633,477...76,640,188
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
affects response to substance |
ISO |
CNR1 affects the susceptibility to Buspirone |
CTD |
PMID:15081793 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cobll1 |
cordon-bleu WH2 repeat protein-like 1 |
increases expression |
EXP |
Buspirone results in increased expression of COBLL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:49,753,260...49,915,168
Ensembl chr 3:49,753,262...49,915,194
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
decreases expression |
EXP |
Buspirone results in decreased expression of COL14A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
decreases expression |
EXP |
Buspirone results in decreased expression of COL1A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
EXP |
Buspirone results in decreased expression of COL3A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Commd5 |
COMM domain containing 5 |
increases expression |
EXP |
Buspirone results in increased expression of COMMD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:108,621,766...108,623,616
Ensembl chr 7:108,598,673...108,624,764
|
|
G |
Copg1 |
COPI coat complex subunit gamma 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of COPG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
|
|
G |
Coro1c |
coronin 1C |
decreases expression |
EXP |
Buspirone results in decreased expression of CORO1C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:42,713,024...42,785,179
Ensembl chr12:42,712,991...42,785,179
|
|
G |
Cox14 |
cytochrome c oxidase assembly factor COX14 |
increases expression |
EXP |
Buspirone results in increased expression of COX14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:130,852,226...130,854,316
|
|
G |
Cox7a2l |
cytochrome c oxidase subunit 7A2 like |
increases expression |
EXP |
Buspirone results in increased expression of COX7A2L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:11,184,064...11,198,287
Ensembl chr 6:11,184,285...11,198,273
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
increases expression |
EXP |
Buspirone results in increased expression of CPT1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
increases expression |
EXP |
Buspirone results in increased expression of CPT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Crem |
cAMP responsive element modulator |
decreases expression |
EXP |
Buspirone results in decreased expression of CREM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of CRY1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cse1l |
chromosome segregation 1 like |
decreases expression |
EXP |
Buspirone results in decreased expression of CSE1L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:155,641,104...155,678,866
Ensembl chr 3:155,641,166...155,678,865
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
decreases expression |
EXP |
Buspirone results in decreased expression of CSF1R mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csnk2a2 |
casein kinase 2 alpha 2 |
increases expression |
EXP |
Buspirone results in increased expression of CSNK2A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:9,556,443...9,596,080
Ensembl chr19:9,556,260...9,596,080
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of CSRP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Ctsd |
cathepsin D |
increases expression |
EXP |
Buspirone results in increased expression of CTSD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ctsl |
cathepsin L |
increases expression |
EXP |
Buspirone results in increased expression of CTSL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Ctss |
cathepsin S |
decreases expression |
EXP |
Buspirone results in decreased expression of CTSS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Ctsz |
cathepsin Z |
decreases expression |
EXP |
Buspirone results in decreased expression of CTSZ mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:163,224,875...163,235,645
Ensembl chr 3:163,224,875...163,235,645
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
increases expression |
EXP |
Buspirone results in increased expression of CXCL11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cybb |
cytochrome b-245 beta chain |
decreases expression |
EXP |
Buspirone results in decreased expression of CYBB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
increases expression |
EXP |
Buspirone results in increased expression of CYP27A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2c22 |
cytochrome P450, family 2, subfamily c, polypeptide 22 |
decreases expression |
EXP |
Buspirone results in decreased expression of CYP2C22 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:238,991,698...239,031,323
Ensembl chr 1:238,991,610...239,021,738
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
increases oxidation increases expression |
ISO EXP |
CYP2D6 protein results in increased oxidation of Buspirone Buspirone results in increased expression of CYP2D4 mRNA |
CTD |
PMID:15640381 PMID:24136188 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2j3 |
cytochrome P450, family 2, subfamily j, polypeptide 3 |
increases expression |
EXP |
Buspirone results in increased expression of CYP2J3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:111,219,921...111,244,987
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases oxidation increases metabolic processing multiple interactions |
ISO |
CYP3A4 protein results in increased oxidation of Buspirone CYP3A4 protein results in increased metabolism of Buspirone Resveratrol inhibits the reaction [CYP3A4 protein results in increased metabolism of Buspirone] |
CTD |
PMID:15640381 PMID:20716633 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases oxidation increases expression |
ISO EXP |
CYP3A5 protein results in increased oxidation of Buspirone Buspirone results in increased expression of CYP3A9 mRNA |
CTD |
PMID:15640381 PMID:24136188 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
increases expression |
EXP |
Buspirone results in increased expression of CYP4A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
increases expression |
EXP |
Buspirone results in increased expression of CYP4B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
|
|
G |
Cyp4f1 |
cytochrome P450, family 4, subfamily f, polypeptide 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of CYP4F1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046
|
|
G |
Cyp4f4 |
cytochrome P450, family 4, subfamily f, polypeptide 4 |
increases expression |
EXP |
Buspirone results in increased expression of CYP4F4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:11,717,208...11,733,507
Ensembl chr 7:11,717,208...11,733,506
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
increases expression |
EXP |
Buspirone results in increased expression of CYP8B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of DAAM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:90,389,544...90,550,114
Ensembl chr 6:90,389,688...90,550,114
|
|
G |
Dab2 |
DAB adaptor protein 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of DAB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
|
|
G |
Dapk1 |
death associated protein kinase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of DAPK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Dbi |
diazepam binding inhibitor |
decreases expression |
EXP |
Buspirone results in decreased expression of DBI mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
|
|
G |
Ddc |
dopa decarboxylase |
decreases expression |
EXP |
Buspirone results in decreased expression of DDC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddhd1 |
DDHD domain containing 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of DDHD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:18,824,389...18,891,036
Ensembl chr15:18,824,394...18,890,952
|
|
G |
Ddx1 |
DEAD-box helicase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of DDX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:35,996,469...36,027,340
Ensembl chr 6:35,996,469...36,027,365
|
|
G |
Decr1 |
2,4-dienoyl-CoA reductase 1 |
increases expression |
EXP |
Buspirone results in increased expression of DECR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:29,411,172...29,439,054
Ensembl chr 5:29,411,172...29,439,018
|
|
G |
Dek |
DEK proto-oncogene |
decreases expression |
EXP |
Buspirone results in decreased expression of DEK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
|
|
G |
Deptor |
DEP domain containing MTOR-interacting protein |
increases expression |
EXP |
Buspirone results in increased expression of DEPTOR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
increases expression |
EXP |
Buspirone results in increased expression of DHRS7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
decreases expression |
EXP |
Buspirone results in decreased expression of DLD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
increases expression |
EXP |
Buspirone results in increased expression of DNAJB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajc9 |
DnaJ heat shock protein family (Hsp40) member C9 |
decreases expression |
EXP |
Buspirone results in decreased expression of DNAJC9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:3,923,842...3,928,118
Ensembl chr15:3,923,268...3,928,118
|
|
G |
Dpm1 |
dolichyl-phosphate mannosyltransferase subunit 1, catalytic |
increases expression |
EXP |
Buspirone results in increased expression of DPM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:156,919,979...156,939,522
Ensembl chr 3:156,919,979...156,939,536
|
|
G |
Dpm3 |
dolichyl-phosphate mannosyltransferase subunit 3, regulatory |
increases expression |
EXP |
Buspirone results in increased expression of DPM3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:174,676,532...174,677,047
Ensembl chr 2:174,676,363...174,677,668 Ensembl chr15:174,676,363...174,677,668
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of DPYSL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Dtymk |
deoxythymidylate kinase |
decreases expression |
EXP |
Buspirone results in decreased expression of DTYMK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:94,315,552...94,324,386
Ensembl chr 9:94,315,552...94,324,870
|
|
G |
Dut |
deoxyuridine triphosphatase |
decreases expression |
EXP |
Buspirone results in decreased expression of DUT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of DYNLL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
|
|
G |
Dynlt3 |
dynein light chain Tctex-type 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of DYNLT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:13,327,933...13,337,139
Ensembl chr X:13,327,892...13,337,139
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
increases expression |
EXP |
Buspirone results in increased expression of ECH1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Echdc1 |
ethylmalonyl-CoA decarboxylase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ECHDC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:28,476,354...28,507,173
Ensembl chr 1:28,476,200...28,507,319
|
|
G |
Echdc3 |
enoyl CoA hydratase domain containing 3 |
increases expression |
EXP |
Buspirone results in increased expression of ECHDC3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
increases expression |
EXP |
Buspirone results in increased expression of ECI1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
increases expression |
EXP |
Buspirone results in increased expression of EDEM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
|
|
G |
Eftud2 |
elongation factor Tu GTP binding domain containing 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of EFTUD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:87,804,893...87,852,181
Ensembl chr10:87,804,892...87,846,079
|
|
G |
Ehbp1 |
EH domain binding protein 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of EHBP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332
|
|
G |
Ei24 |
EI24, autophagy associated transmembrane protein |
increases expression |
EXP |
Buspirone results in increased expression of EI24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571
|
|
G |
Eif3c |
eukaryotic translation initiation factor 3, subunit C |
decreases expression |
EXP |
Buspirone results in decreased expression of EIF3C mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:181,134,604...181,152,489
Ensembl chr 1:181,134,604...181,152,493
|
|
G |
Eif3l |
eukaryotic translation initiation factor 3, subunit L |
decreases expression |
EXP |
Buspirone results in decreased expression of EIF3L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:110,652,565...110,663,614
Ensembl chr 7:110,627,107...110,663,614
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
increases expression |
EXP |
Buspirone results in increased expression of EIF4A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:77,764,126...77,770,810
Ensembl chr11:77,764,124...77,770,781
|
|
G |
Eif4b |
eukaryotic translation initiation factor 4B |
increases expression |
EXP |
Buspirone results in increased expression of EIF4B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:133,206,637...133,228,436
|
|
G |
Elovl5 |
ELOVL fatty acid elongase 5 |
decreases expression |
EXP |
Buspirone results in decreased expression of ELOVL5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:78,790,846...78,857,307
Ensembl chr 8:78,790,846...78,857,284
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
decreases expression |
EXP |
Buspirone results in decreased expression of ELOVL6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Enpep |
glutamyl aminopeptidase |
decreases expression |
EXP |
Buspirone results in decreased expression of ENPEP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:217,781,985...217,851,947
Ensembl chr 2:217,782,005...217,851,947
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of EPHX1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Erg28 |
ergosterol biosynthesis 28 homolog |
increases expression |
EXP |
Buspirone results in increased expression of ERG28 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:105,474,112...105,483,078
Ensembl chr 6:105,474,113...105,483,078
|
|
G |
Ergic1 |
endoplasmic reticulum-golgi intermediate compartment 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ERGIC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:16,531,192...16,626,974
Ensembl chr10:16,531,194...16,626,957
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
decreases expression |
EXP |
Buspirone results in decreased expression of ERP29 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
|
|
G |
Etnk2 |
ethanolamine kinase 2 |
increases expression |
EXP |
Buspirone results in increased expression of ETNK2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:44,811,012...44,829,052
Ensembl chr13:44,811,015...44,829,037
|
|
G |
Ewsr1 |
EWS RNA-binding protein 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of EWSR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:79,965,365...79,994,108
Ensembl chr14:79,965,368...79,994,544
|
|
G |
Exosc5 |
exosome component 5 |
increases expression |
EXP |
Buspirone results in increased expression of EXOSC5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:81,168,128...81,177,266
Ensembl chr 1:81,166,023...81,177,265
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
decreases expression |
EXP |
Buspirone results in decreased expression of FABP5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
|
|
G |
Fads1 |
fatty acid desaturase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of FADS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fads2 |
fatty acid desaturase 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of FADS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Fam111a |
FAM111 trypsin like peptidase A |
decreases expression |
EXP |
Buspirone results in decreased expression of FAM111A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547
|
|
G |
Fam98a |
family with sequence similarity 98, member A |
decreases expression |
EXP |
Buspirone results in decreased expression of FAM98A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:19,874,082...19,888,744
Ensembl chr 6:19,874,071...19,888,742
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
EXP |
Buspirone results in decreased expression of FASN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of FAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
|
|
G |
Fbxo31 |
F-box protein 31 |
increases expression |
EXP |
Buspirone results in increased expression of FBXO31 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:49,624,813...49,656,052
Ensembl chr19:49,627,686...49,656,010
|
|
G |
Fbxw2 |
F-box and WD repeat domain containing 2 |
increases expression |
EXP |
Buspirone results in increased expression of FBXW2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:18,088,859...18,114,387
Ensembl chr 3:18,088,865...18,114,381
|
|
G |
Fcgr2a |
Fc gamma receptor 2A |
decreases expression |
EXP |
Buspirone results in decreased expression of FCGR2A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
|
|
G |
Fez2 |
fasciculation and elongation protein zeta 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of FEZ2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:16,654,572...16,694,628
Ensembl chr 6:16,654,614...16,694,626
|
|
G |
Fga |
fibrinogen alpha chain |
decreases expression |
EXP |
Buspirone results in decreased expression of FGA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of FGFR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fjx1 |
four-jointed box kinase 1 |
increases expression |
EXP |
Buspirone results in increased expression of ANKHD1-EIF4EBP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:88,774,220...88,776,321
Ensembl chr 3:88,774,220...88,776,321
|
|
G |
Flcn |
folliculin |
increases expression |
EXP |
Buspirone results in increased expression of FLCN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
increases expression |
EXP |
Buspirone results in increased expression of FMO3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
increases expression |
EXP |
Buspirone results in increased expression of FMO5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
|
|
G |
Foxa3 |
forkhead box A3 |
increases expression |
EXP |
Buspirone results in increased expression of FOXA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155
|
|
G |
Foxo1 |
forkhead box O1 |
increases expression |
EXP |
Buspirone results in increased expression of FOXO1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Fstl1 |
follistatin-like 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of FSTL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:62,895,391...62,948,581
Ensembl chr11:62,779,783...62,948,677
|
|
G |
Ftcd |
formimidoyltransferase cyclodeaminase |
increases expression |
EXP |
Buspirone results in increased expression of FTCD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735
|
|
G |
Fus |
Fus RNA binding protein |
decreases expression |
EXP |
Buspirone results in decreased expression of FUS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:182,576,479...182,590,417
Ensembl chr 1:182,576,545...182,590,414
|
|
G |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
increases expression |
EXP |
Buspirone results in increased expression of FXYD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:86,287,163...86,291,478
Ensembl chr 1:86,287,165...86,291,278
|
|
G |
G0s2 |
G0/G1switch 2 |
increases expression |
EXP |
Buspirone results in increased expression of G0S2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
decreases expression |
EXP |
Buspirone results in decreased expression of G6PD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
decreases expression |
EXP |
Buspirone results in decreased expression of GADD45G mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of GALNT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:15,489,015...15,568,849
Ensembl chr18:15,489,020...15,568,245
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of GARS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
|
|
G |
Gas5 |
growth arrest specific 5 |
increases expression |
EXP |
Buspirone results in increased expression of GAS5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:73,303,611...73,306,932
|
|
G |
Gbe1 |
1,4-alpha-glucan branching enzyme 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of GBE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
|
|
G |
Gcdh |
glutaryl-CoA dehydrogenase |
increases expression |
EXP |
Buspirone results in increased expression of GCDH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:23,263,215...23,269,689
Ensembl chr19:23,263,264...23,269,681
|
|
G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
increases expression |
EXP |
Buspirone results in increased expression of GCHFR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
decreases expression |
EXP |
Buspirone results in decreased expression of GCLC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gde1 |
glycerophosphodiester phosphodiesterase 1 |
increases expression |
EXP |
Buspirone results in increased expression of GDE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:173,016,984...173,032,396
Ensembl chr 1:172,954,394...173,032,429
|
|
G |
Gdi2 |
GDP dissociation inhibitor 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of GDI2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:66,649,616...66,676,299
Ensembl chr17:66,649,619...66,676,366
|
|
G |
Gfm1 |
G elongation factor, mitochondrial 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of GFM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:151,700,573...151,745,477
Ensembl chr 2:151,700,564...151,745,471
|
|
G |
Ggcx |
gamma-glutamyl carboxylase |
decreases expression |
EXP |
Buspirone results in decreased expression of GGCX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:104,469,737...104,485,631
Ensembl chr 4:104,469,765...104,487,063
|
|
G |
Ghr |
growth hormone receptor |
decreases expression |
EXP |
Buspirone results in decreased expression of GHR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Gldc |
glycine decarboxylase |
decreases expression |
EXP |
Buspirone results in decreased expression of GLDC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
|
|
G |
Glrx |
glutaredoxin |
increases expression |
EXP |
Buspirone results in increased expression of GLRX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Glyat |
glycine-N-acyltransferase |
increases expression |
EXP |
Buspirone results in increased expression of GLYAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
|
|
G |
Gnpnat1 |
glucosamine-phosphate N-acetyltransferase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of GNPNAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:18,596,180...18,608,854
Ensembl chr15:18,596,442...18,608,739
|
|
G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
decreases expression |
EXP |
Buspirone results in decreased expression of GPAM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of GPD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression |
EXP |
Buspirone results in increased expression of GPT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gspt1 |
G1 to S phase transition 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of GSPT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:4,362,528...4,397,215
Ensembl chr10:4,362,510...4,397,198
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP |
Buspirone results in increased expression of GSTP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt2 |
glutathione S-transferase theta 2 |
increases expression |
EXP |
Buspirone results in increased expression of GSTT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288
|
|
G |
H1f0 |
H1.0 linker histone |
decreases expression |
EXP |
Buspirone results in decreased expression of H1F0 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
|
|
G |
H2az1 |
H2A.Z variant histone 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of H2AZ1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:226,355,668...226,357,984
Ensembl chr 2:226,355,708...226,358,485
|
|
G |
Hacd2 |
3-hydroxyacyl-CoA dehydratase 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of HACD2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:65,667,671...65,762,903
Ensembl chr11:65,670,281...65,762,889
|
|
G |
Hacd3 |
3-hydroxyacyl-CoA dehydratase 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of HACD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:65,501,240...65,538,507
Ensembl chr 8:65,501,240...65,538,507
|
|
G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
increases expression |
EXP |
Buspirone results in increased expression of HACL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:6,826,881...6,863,027
Ensembl chr16:6,824,906...6,863,027
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
increases expression |
EXP |
Buspirone results in increased expression of HADHB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hao1 |
hydroxyacid oxidase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of HAO1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:121,757,400...121,828,721
Ensembl chr 3:121,771,836...121,828,721
|
|
G |
Hat1 |
histone acetyltransferase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of HAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
|
|
G |
Haus4 |
HAUS augmin-like complex, subunit 4 |
decreases expression |
EXP |
Buspirone results in decreased expression of HAUS4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:27,994,530...28,006,147
Ensembl chr15:27,994,532...28,005,938
|
|
G |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of HBA-A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:15,337,265...15,338,121
Ensembl chr10:15,307,815...15,338,392
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of HBA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392 Ensembl chr10:15,307,815...15,338,392
|
|
G |
Hectd1 |
HECT domain E3 ubiquitin protein ligase 1 |
increases expression |
EXP |
Buspirone results in increased expression of HECTD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:69,181,429...69,268,045
Ensembl chr 6:69,181,436...69,268,053
|
|
G |
Herpud1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
increases expression |
EXP |
Buspirone results in increased expression of HERPUD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
increases expression |
EXP |
Buspirone results in increased expression of HES1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hes6 |
hes family bHLH transcription factor 6 |
decreases expression |
EXP |
Buspirone results in decreased expression of HES6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
|
|
G |
Hexb |
hexosaminidase subunit beta |
increases expression |
EXP |
Buspirone results in increased expression of HEXB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Hhex |
hematopoietically expressed homeobox |
decreases expression |
EXP |
Buspirone results in decreased expression of HHEX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:235,190,455...235,196,042
Ensembl chr 1:235,190,455...235,196,042
|
|
G |
Hibch |
3-hydroxyisobutyryl-CoA hydrolase |
increases expression |
EXP |
Buspirone results in increased expression of HIBCH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:48,590,097...48,669,896
Ensembl chr 9:48,590,099...48,669,824
|
|
G |
Higd2a |
HIG1 hypoxia inducible domain family, member 2A |
increases expression |
EXP |
Buspirone results in increased expression of HIGD2A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:10,021,853...10,022,777
Ensembl chr17:10,021,859...10,022,796
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of HMGB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140 Ensembl chr 1:32,710,658...32,713,140
|
|
G |
Hmgn2 |
high mobility group nucleosomal binding domain 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of HMGN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:146,192,126...146,195,580
Ensembl chr 5:146,192,126...146,195,521 Ensembl chr16:146,192,126...146,195,521
|
|
G |
Hmgn3 |
high mobility group nucleosomal binding domain 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of HMGN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:84,022,493...84,059,329
Ensembl chr 8:84,022,495...84,062,976
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
EXP |
Buspirone inhibits the reaction [Methotrexate results in decreased expression of HMOX1 mRNA] Buspirone results in increased expression of HMOX1 mRNA |
CTD |
PMID:37341015 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
decreases expression |
EXP |
Buspirone results in decreased expression of HNRNPA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
decreases expression |
EXP |
Buspirone results in decreased expression of HNRNPA2B1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
|
|
G |
Hnrnpm |
heterogeneous nuclear ribonucleoprotein M |
decreases expression |
EXP |
Buspirone results in decreased expression of HNRNPM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:14,438,703...14,476,781
Ensembl chr 7:14,438,688...14,476,762
|
|
G |
Hnrnpr |
heterogeneous nuclear ribonucleoprotein R |
decreases expression |
EXP |
Buspirone results in decreased expression of HNRNPR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:148,542,999...148,574,888
Ensembl chr 5:148,543,044...148,574,867
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
increases expression |
EXP |
Buspirone results in increased expression of HPRT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
increases expression |
EXP |
Buspirone results in increased expression of HSDL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:74,443,872...74,479,839
|
|
G |
Hspa13 |
heat shock protein family A (Hsp70) member 13 |
decreases expression |
EXP |
Buspirone results in decreased expression of HSPA13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
EXP |
Buspirone results in decreased expression of HSPA5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Htatsf1 |
HIV-1 Tat specific factor 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of HTATSF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:134,935,426...134,949,607
Ensembl chr X:134,935,426...134,949,607
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
multiple interactions |
ISO EXP |
Buspirone binds to and affects the activity of HTR1A protein Buspirone binds to and results in decreased activity of HTR1A protein |
CTD |
PMID:2207497 PMID:15482641 |
|
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
decreases expression |
EXP |
Buspirone results in decreased expression of HTR2A protein |
CTD |
PMID:1664741 |
|
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
|
|
G |
Hyal3 |
hyaluronidase 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of HYAL3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,254,385...108,260,020
Ensembl chr 8:108,250,667...108,260,647
|
|
G |
Hycc2 |
hyccin PI4KA lipid kinase complex subunit 2 |
increases expression |
EXP |
Buspirone results in increased expression of HYCC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:60,056,883...60,129,176
Ensembl chr 9:60,056,890...60,093,007
|
|
G |
Iars1 |
isoleucyl-tRNA synthetase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of IARS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:14,940,919...14,987,277
Ensembl chr17:14,940,924...14,987,237
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ICAM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of IFIT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of IFITM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of IGF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
decreases expression |
EXP |
Buspirone results in decreased expression of IGFBP7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:30,737,414...30,797,317
Ensembl chr14:30,737,164...30,797,314
|
|
G |
Ik |
IK cytokine |
decreases expression |
EXP |
Buspirone results in decreased expression of IK mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:28,358,004...28,372,809
Ensembl chr18:28,357,977...28,378,832
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
Buspirone inhibits the reaction [Methotrexate results in increased expression of IL1B protein] |
CTD |
PMID:37341015 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
Buspirone inhibits the reaction [Methotrexate results in increased expression of IL6 protein] |
CTD |
PMID:37341015 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
increases expression |
EXP |
Buspirone results in increased expression of IL6R mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Imp3 |
IMP U3 small nucleolar ribonucleoprotein 3 |
increases expression |
EXP |
Buspirone results in increased expression of IMP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:57,339,528...57,340,416
Ensembl chr 8:57,339,496...57,340,414
|
|
G |
Inhba |
inhibin subunit beta A |
decreases expression |
EXP |
Buspirone results in decreased expression of INHBA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Ip6k1 |
inositol hexakisphosphate kinase 1 |
increases expression |
EXP |
Buspirone results in increased expression of IP6K1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,693,068...108,737,278
|
|
G |
Ipo9 |
importin 9 |
decreases expression |
EXP |
Buspirone results in decreased expression of IPO9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:46,810,460...46,862,694
Ensembl chr13:46,813,171...46,862,673
|
|
G |
Irf1 |
interferon regulatory factor 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of IRF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Irf7 |
interferon regulatory factor 7 |
decreases expression |
EXP |
Buspirone results in decreased expression of IRF7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
|
|
G |
Irgm |
immunity-related GTPase M |
decreases expression |
EXP |
Buspirone results in decreased expression of IRGM mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
|
|
G |
Itga6 |
integrin subunit alpha 6 |
decreases expression |
EXP |
Buspirone results in decreased expression of ITGA6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
|
|
G |
Itgb2 |
integrin subunit beta 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of ITGB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Jak1 |
Janus kinase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of JAK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Jam2 |
junctional adhesion molecule 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of JAM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063
|
|
G |
Jpt2 |
Jupiter microtubule associated homolog 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of JPT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,963,135...13,983,212
Ensembl chr10:13,963,137...13,983,170
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
EXP |
Buspirone results in decreased expression of JUN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Jup |
junction plakoglobin |
decreases expression |
EXP |
Buspirone results in decreased expression of JUP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:85,300,438...85,327,378
Ensembl chr10:85,300,440...85,327,057
|
|
G |
Kctd5 |
potassium channel tetramerization domain containing 5 |
increases expression |
EXP |
Buspirone results in increased expression of KCTD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,079,216...13,105,197
Ensembl chr10:13,079,214...13,105,209
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions |
EXP |
Buspirone inhibits the reaction [Methotrexate results in increased expression of KEAP1 mRNA] |
CTD |
PMID:37341015 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Khdrbs1 |
KH RNA binding domain containing, signal transduction associated 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of KHDRBS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:142,051,844...142,089,175
Ensembl chr 5:142,063,570...142,089,180
|
|
G |
Klf15 |
KLF transcription factor 15 |
increases expression |
EXP |
Buspirone results in increased expression of KLF15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
|
|
G |
Klf9 |
KLF transcription factor 9 |
increases expression |
EXP |
Buspirone results in increased expression of KLF9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037
|
|
G |
Klhl24 |
kelch-like family member 24 |
increases expression |
EXP |
Buspirone results in increased expression of KLHL24 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
|
|
G |
Kpna2 |
karyopherin subunit alpha 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of KPNA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
|
|
G |
Kpnb1 |
karyopherin subunit beta 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of KPNB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
|
|
G |
Krt18 |
keratin 18 |
decreases expression |
EXP |
Buspirone results in decreased expression of KRT18 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
|
|
G |
Kyat1 |
kynurenine aminotransferase 1 |
increases expression |
EXP |
Buspirone results in increased expression of KYAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355
|
|
G |
Kyat3 |
kynurenine aminotransferase 3 |
increases expression |
EXP |
Buspirone results in increased expression of KYAT3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:231,701,881...231,747,462
Ensembl chr 2:231,701,963...231,747,227
|
|
G |
Lactb |
lactamase, beta |
decreases expression |
EXP |
Buspirone results in decreased expression of LACTB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:67,571,504...67,587,592
Ensembl chr 8:67,571,500...67,587,539
|
|
G |
Lamtor2 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 |
increases expression |
EXP |
Buspirone results in increased expression of LAMTOR2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:174,008,556...174,011,950
Ensembl chr 2:174,008,548...174,013,013
|
|
G |
Lbp |
lipopolysaccharide binding protein |
increases expression |
EXP |
Buspirone results in increased expression of LBP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
|
|
G |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of LCMT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:177,904,119...177,960,111
Ensembl chr 1:177,904,139...177,960,112
|
|
G |
Lcp1 |
lymphocyte cytosolic protein 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of LCP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680
|
|
G |
Leprotl1 |
leptin receptor overlapping transcript-like 1 |
increases expression |
EXP |
Buspirone results in increased expression of LEPROTL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:58,040,934...58,053,602
Ensembl chr16:58,040,960...58,053,593
|
|
G |
Letm1 |
leucine zipper and EF-hand containing transmembrane protein 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of LETM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:76,942,647...76,982,220
Ensembl chr14:76,942,729...76,984,904
|
|
G |
Lgals3 |
galectin 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of LGALS3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Lgals5 |
galectin 5 |
decreases expression |
EXP |
Buspirone results in decreased expression of LGALS5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:63,853,949...63,857,198
Ensembl chr10:63,853,935...63,857,153
|
|
G |
Lgals9 |
galectin 9 |
decreases expression |
EXP |
Buspirone results in decreased expression of LGALS9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
|
|
G |
Lgalsl |
galectin-like |
decreases expression |
EXP |
Buspirone results in decreased expression of LGALSL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
|
|
G |
Lgmn |
legumain |
decreases expression |
EXP |
Buspirone results in decreased expression of LGMN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:121,544,048...121,582,495
Ensembl chr 6:121,544,053...121,582,480
|
|
G |
Lipc |
lipase C, hepatic type |
decreases expression |
EXP |
Buspirone results in decreased expression of LIPC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lman1 |
lectin, mannose-binding, 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of LMAN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:59,508,996...59,530,873
Ensembl chr18:59,508,996...59,530,851
|
|
G |
Lrat |
lecithin retinol acyltransferase |
decreases expression |
EXP |
Buspirone results in decreased expression of LRAT mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
|
|
G |
Lrp11 |
LDL receptor related protein 11 |
increases expression |
EXP |
Buspirone results in increased expression of LRP11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:2,048,307...2,108,115
Ensembl chr 1:2,079,438...2,108,110
|
|
G |
Lrrc59 |
leucine rich repeat containing 59 |
decreases expression |
EXP |
Buspirone results in decreased expression of LRRC59 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:79,572,295...79,586,953
Ensembl chr10:79,572,317...79,602,533
|
|
G |
Lsm6 |
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated |
decreases expression |
EXP |
Buspirone results in decreased expression of LSM6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:29,098,254...29,112,858
Ensembl chr13:42,114,032...42,116,484 Ensembl chr19:42,114,032...42,116,484
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
decreases expression |
EXP |
Buspirone results in decreased expression of LTA4H mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:27,969,796...28,001,600
Ensembl chr 7:27,969,789...28,001,600
|
|
G |
Ly6e |
lymphocyte antigen 6 family member E |
decreases expression |
EXP |
Buspirone results in decreased expression of LY6E mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
|
|
G |
Lyve1 |
lymphatic vessel endothelial hyaluronan receptor 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of LYVE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:164,962,872...164,976,309
Ensembl chr 1:164,962,872...164,976,309
|
|
G |
Lyz2 |
lysozyme 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of LYZ2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression |
EXP |
Buspirone results in increased expression of MAP1LC3B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
decreases expression |
EXP |
Buspirone results in decreased expression of MAPK9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mapre1 |
microtubule-associated protein, RP/EB family, member 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of MAPRE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:142,218,846...142,246,990
Ensembl chr 3:142,212,955...142,246,983
|
|
G |
Marchf2 |
membrane associated ring-CH-type finger 2 |
increases expression |
EXP |
Buspirone results in increased expression of MARCHF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:14,480,605...14,507,821
Ensembl chr 7:14,481,761...14,507,794
|
|
G |
Marchf6 |
membrane associated ring-CH-type finger 6 |
increases expression |
EXP |
Buspirone results in increased expression of MARCHF6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:82,455,686...82,532,917
Ensembl chr 2:82,455,689...82,532,910
|
|
G |
Marcksl1 |
MARCKS-like 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of MARCKSL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
|
|
G |
Marf1 |
meiosis regulator and mRNA stability factor 1 |
increases expression |
EXP |
Buspirone results in increased expression of MARF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:888,053...932,760
Ensembl chr10:888,076...932,753
|
|
G |
Mat1a |
methionine adenosyltransferase 1A |
increases expression |
EXP |
Buspirone results in increased expression of MAT1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:16,983,084...17,001,284
Ensembl chr16:16,983,022...17,001,274
|
|
G |
Mbl2 |
mannose binding lectin 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of MBL2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mcm7 |
minichromosome maintenance complex component 7 |
decreases expression |
EXP |
Buspirone results in decreased expression of MCM7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
|
|
G |
Me1 |
malic enzyme 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ME1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mettl23 |
methyltransferase 23, arginine |
increases expression |
EXP |
Buspirone results in increased expression of METTL23 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:102,047,090...102,053,379
Ensembl chr10:102,047,314...102,051,977
|
|
G |
Mfsd2a |
MFSD2 lysolipid transporter A, lysophospholipid |
increases expression |
EXP |
Buspirone results in increased expression of MFSD2A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
|
|
G |
Mgll |
monoglyceride lipase |
decreases expression |
EXP |
Buspirone results in decreased expression of MGLL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
G |
Mid1ip1 |
MID1 interacting protein 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of MID1IP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:12,060,993...12,063,318
Ensembl chr X:12,060,883...12,065,774
|
|
G |
Mif |
macrophage migration inhibitory factor |
decreases expression |
EXP |
Buspirone results in decreased expression of MIF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
|
|
G |
Morf4l2 |
mortality factor 4 like 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of MORF4L2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:100,082,562...100,093,658
Ensembl chr X:100,082,404...100,093,728
|
|
G |
Mrpl1 |
mitochondrial ribosomal protein L1 |
decreases expression |
EXP |
Buspirone results in decreased expression of MRPL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:13,300,522...13,359,654
Ensembl chr14:13,300,522...13,359,721
|
|
G |
Mrpl15 |
mitochondrial ribosomal protein L15 |
decreases expression |
EXP |
Buspirone results in decreased expression of MRPL15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:14,729,961...14,741,276
Ensembl chr 5:14,729,979...14,741,276
|
|
G |
Mrpl34 |
mitochondrial ribosomal protein L34 |
increases expression |
EXP |
Buspirone results in increased expression of MRPL34 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:18,152,470...18,153,205
Ensembl chr16:18,151,342...18,153,208
|
|
G |
Mrps22 |
mitochondrial ribosomal protein S22 |
decreases expression |
EXP |
Buspirone results in decreased expression of MRPS22 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:99,184,110...99,197,278
Ensembl chr 8:99,184,109...99,197,291
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
EXP |
Buspirone results in increased expression of MT1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Mtarc2 |
mitochondrial amidoxime reducing component 2 |
increases expression |
EXP |
Buspirone results in increased expression of MTARC2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:96,362,810...96,397,284
|
|
G |
Mthfd1 |
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of MTHFD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:94,977,862...95,045,375
Ensembl chr 6:94,977,862...95,045,372
|
|
G |
Mtss1 |
MTSS I-BAR domain containing 1 |
increases expression |
EXP |
Buspirone results in increased expression of MTSS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
decreases expression |
EXP |
Buspirone results in decreased expression of MTTP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Mug1 |
murinoglobulin 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of MUG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:155,076,270...155,130,051
Ensembl chr 4:155,076,312...155,130,051
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
increases expression |
EXP |
Buspirone results in increased expression of MYD88 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Myh9 |
myosin, heavy chain 9 |
decreases expression |
EXP |
Buspirone results in decreased expression of MYH9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
|
|
G |
Naa15 |
N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
decreases expression |
EXP |
Buspirone results in decreased expression of NAA15 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:135,458,018...135,520,756
Ensembl chr 2:135,457,948...135,520,756
|
|
G |
Nans |
N-acetylneuraminate synthase |
decreases expression |
EXP |
Buspirone results in decreased expression of NANS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:60,780,441...60,797,583
Ensembl chr 5:60,780,392...60,814,950
|
|
G |
Ndfip1 |
Nedd4 family interacting protein 1 |
increases expression |
EXP |
Buspirone results in increased expression of NDFIP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:30,265,808...30,316,068
Ensembl chr18:30,250,613...30,322,311
|
|
G |
Ndufa6 |
NADH:ubiquinone oxidoreductase subunit A6 |
increases expression |
EXP |
Buspirone results in increased expression of NDUFA6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:113,866,382...113,870,239
Ensembl chr 7:113,866,382...113,870,239
|
|
G |
Ndufa7 |
NADH:ubiquinone oxidoreductase subunit A7 |
increases expression |
EXP |
Buspirone results in increased expression of NDUFA7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:14,609,283...14,622,064
Ensembl chr 7:14,609,146...14,631,976
|
|
G |
Ndufb2 |
NADH:ubiquinone oxidoreductase subunit B2 |
increases expression |
EXP |
Buspirone results in increased expression of NDUFB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:68,367,526...68,374,609
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
|
|
G |
Nectin3 |
nectin cell adhesion molecule 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of NECTIN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:54,362,712...54,469,351
Ensembl chr11:54,364,487...54,462,519
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
decreases expression multiple interactions increases expression |
EXP |
Buspirone results in decreased expression of NFE2L2 mRNA Buspirone inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA] Buspirone results in increased expression of NFE2L2 mRNA |
CTD |
PMID:24136188 PMID:37341015 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nhp2 |
NHP2 ribonucleoprotein |
decreases expression |
EXP |
Buspirone results in decreased expression of NHP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:35,877,057...35,880,399
Ensembl chr10:35,877,054...35,882,545
|
|
G |
Nid1 |
nidogen 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of NID1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:86,085,133...86,158,272
Ensembl chr17:86,085,077...86,158,267
|
|
G |
Nit1 |
nitrilase 1 |
increases expression |
EXP |
Buspirone results in increased expression of NIT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:83,769,888...83,773,324
Ensembl chr13:83,765,941...83,773,332
|
|
G |
Nln |
neurolysin |
decreases expression |
EXP |
Buspirone results in decreased expression of NLN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:35,133,634...35,232,927
Ensembl chr 2:35,134,145...35,232,914
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
EXP |
Buspirone inhibits the reaction [Methotrexate results in increased expression of NLRP3 protein] |
CTD |
PMID:37341015 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of NME1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:78,907,036...78,929,659
Ensembl chr10:78,906,083...78,916,408
|
|
G |
Nme3 |
NME/NM23 nucleoside diphosphate kinase 3 |
increases expression |
EXP |
Buspirone results in increased expression of NME3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:13,917,309...13,918,415
Ensembl chr10:13,917,403...13,918,359
|
|
G |
Nop53 |
NOP53 ribosome biogenesis factor |
increases expression |
EXP |
Buspirone results in increased expression of NOP53 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:76,629,084...76,636,902
Ensembl chr 1:76,629,069...76,636,902
|
|
G |
Nop58 |
NOP58 ribonucleoprotein |
decreases expression |
EXP |
Buspirone results in decreased expression of NOL5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:61,120,939...61,144,810
Ensembl chr 9:61,120,929...61,144,810
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
EXP |
Buspirone inhibits the reaction [Methotrexate results in increased expression of NOS1 mRNA] |
CTD |
PMID:37341015 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Notch2 |
notch receptor 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of NOTCH2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
increases expression |
EXP |
Buspirone results in increased expression of NR1D2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases expression |
EXP |
Buspirone results in increased expression of NR1I2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nrbp2 |
nuclear receptor binding protein 2 |
increases expression |
EXP |
Buspirone results in increased expression of NRBP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:107,798,642...107,805,225
Ensembl chr 7:107,799,497...107,805,230
|
|
G |
Nrep |
neuronal regeneration related protein |
decreases expression |
EXP |
Buspirone results in decreased expression of NREP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
|
|
G |
Nsdhl |
NAD(P) dependent steroid dehydrogenase-like |
decreases expression |
EXP |
Buspirone results in decreased expression of NSDHL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:150,775,034...150,807,161
Ensembl chr X:150,775,080...150,807,142
|
|
G |
Nt5e |
5' nucleotidase, ecto |
decreases expression |
EXP |
Buspirone results in decreased expression of NT5E mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
|
|
G |
Ntpcr |
nucleoside-triphosphatase, cancer-related |
increases expression |
EXP |
Buspirone results in increased expression of NTPCR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:53,701,496...53,715,260
Ensembl chr19:53,695,976...53,715,202
|
|
G |
Nucb2 |
nucleobindin 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of NUCB2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:170,750,830...170,787,356
Ensembl chr 1:170,750,877...170,787,353
|
|
G |
Nudt4 |
nudix hydrolase 4 |
increases expression |
EXP |
Buspirone results in increased expression of NUDT4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:30,188,100...30,204,615
Ensembl chr 7:30,188,100...30,204,615
|
|
G |
Obp3 |
alpha-2u globulin PGCL4 |
increases expression |
EXP |
Buspirone results in increased expression of OBP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:74,842,316...74,845,858
Ensembl chr 5:74,842,316...74,845,757
|
|
G |
Ola1 |
Obg-like ATPase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of OLA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:57,966,896...58,085,955
Ensembl chr 3:57,966,896...58,084,480
|
|
G |
Oplah |
5-oxoprolinase (ATP-hydrolysing) |
increases expression |
EXP |
Buspirone results in increased expression of OPLAH mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:108,011,472...108,051,751
Ensembl chr 7:108,011,475...108,035,297
|
|
G |
Osbpl1a |
oxysterol binding protein-like 1A |
decreases expression |
EXP |
Buspirone results in decreased expression of OSBPL1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:3,904,006...4,094,635
Ensembl chr18:3,904,006...4,094,585
|
|
G |
Pald1 |
phosphatase domain containing, paladin 1 |
increases expression |
EXP |
Buspirone results in increased expression of PALD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:29,269,814...29,334,850
Ensembl chr20:29,270,193...29,334,858
|
|
G |
Palmd |
palmdelphin |
decreases expression |
EXP |
Buspirone results in decreased expression of PALMD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519
|
|
G |
Paqr9 |
progestin and adipoQ receptor family member 9 |
decreases expression |
EXP |
Buspirone results in decreased expression of PAQR9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:96,114,249...96,116,546
|
|
G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
decreases expression |
EXP |
Buspirone results in decreased expression of PARP14 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
|
|
G |
Pbld1 |
phenazine biosynthesis-like protein domain containing 1 |
increases expression |
EXP |
Buspirone results in increased expression of PBLD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
EXP |
Buspirone results in decreased expression of PCNA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pctp |
phosphatidylcholine transfer protein |
decreases expression |
EXP |
Buspirone results in decreased expression of PCTP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:74,808,887...74,856,260
Ensembl chr10:74,808,887...74,849,867
|
|
G |
Pcyt1a |
phosphate cytidylyltransferase 1A, choline |
increases expression |
EXP |
Buspirone results in increased expression of PCYT1A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:68,313,860...68,357,828
Ensembl chr11:68,313,882...68,357,357
|
|
G |
Pdcd4 |
programmed cell death 4 |
decreases expression |
EXP |
Buspirone results in decreased expression of PDCD4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
|
|
G |
Pde4b |
phosphodiesterase 4B |
decreases expression |
EXP |
Buspirone results in decreased expression of PDE4B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Pdia5 |
protein disulfide isomerase family A, member 5 |
decreases expression |
EXP |
Buspirone results in decreased expression of PDIA5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:65,272,152...65,359,087
Ensembl chr11:65,272,155...65,359,084
|
|
G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
decreases expression |
EXP |
Buspirone results in decreased expression of PDIA6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
|
|
G |
Pdlim1 |
PDZ and LIM domain 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of PDLIM1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:239,042,372...239,091,074
Ensembl chr 1:239,042,385...239,091,076
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
increases expression |
EXP |
Buspirone results in increased expression of PEX11A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
decreases expression |
EXP |
Buspirone results in decreased expression of PGD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of PGK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Phf11 |
PHD finger protein 11 |
decreases expression |
EXP |
Buspirone results in decreased expression of PHF11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:33,390,290...33,414,647
Ensembl chr15:33,390,292...33,413,009
|
|
G |
Phyhd1 |
phytanoyl-CoA dioxygenase domain containing 1 |
increases expression |
EXP |
Buspirone results in increased expression of PHYHD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:13,535,670...13,553,797
Ensembl chr 3:13,540,056...13,553,797
|
|
G |
Pim3 |
Pim-3 proto-oncogene, serine/threonine kinase |
increases expression |
EXP |
Buspirone results in increased expression of PIM3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:119,953,377...119,956,587
Ensembl chr 7:119,953,175...119,956,587
|
|
G |
Pink1 |
PTEN induced kinase 1 |
increases expression |
EXP |
Buspirone results in increased expression of PINK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Pklr |
pyruvate kinase L/R |
decreases expression |
EXP |
Buspirone results in decreased expression of PKLR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pla2g12a |
phospholipase A2, group XIIA |
increases expression |
EXP |
Buspirone results in increased expression of PLA2G12A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:218,436,497...218,452,742
Ensembl chr 2:218,436,513...218,452,740
|
|
G |
Plcb1 |
phospholipase C beta 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of PLCB1 mRNA; Buspirone results in decreased expression of PLCB1 protein |
CTD |
PMID:12527476 |
|
NCBI chr 3:122,059,988...122,772,896
Ensembl chr 3:122,060,031...122,772,869
|
|
G |
Plin2 |
perilipin 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of PLIN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
|
|
G |
Plin3 |
perilipin 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of PLIN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Plpp3 |
phospholipid phosphatase 3 |
increases expression |
EXP |
Buspirone results in increased expression of PLPP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:119,927,085...120,002,206
Ensembl chr 5:119,927,085...120,002,205
|
|
G |
Plxna2 |
plexin A2 |
decreases expression |
EXP |
Buspirone results in decreased expression of PLXNA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:106,163,103...106,358,979
Ensembl chr13:106,163,103...106,358,979
|
|
G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
increases expression |
EXP |
Buspirone results in increased expression of PNPLA2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,552,723...196,557,805
Ensembl chr 1:196,552,723...196,557,805
|
|
G |
Pnpla7 |
patatin-like phospholipase domain containing 7 |
increases expression |
EXP |
Buspirone results in increased expression of PNPLA7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:7,782,572...7,861,504
Ensembl chr 3:7,782,572...7,861,497
|
|
G |
Pnpla8 |
patatin-like phospholipase domain containing 8 |
increases expression |
EXP |
Buspirone results in increased expression of PNPLA8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:61,329,810...61,391,736
Ensembl chr 6:61,329,810...61,391,734
|
|
G |
Pold4 |
DNA polymerase delta 4, accessory subunit |
increases expression |
EXP |
Buspirone results in increased expression of POLD4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:201,526,591...201,528,406
Ensembl chr 1:201,526,665...201,528,401
|
|
G |
Polg2 |
DNA polymerase gamma 2, accessory subunit |
increases expression |
EXP |
Buspirone results in increased expression of POLG2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:91,712,586...91,723,008
Ensembl chr10:91,712,586...91,723,008
|
|
G |
Polr2b |
RNA polymerase II subunit B |
decreases expression |
EXP |
Buspirone results in decreased expression of POLR2B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:30,797,228...30,834,916
Ensembl chr14:30,797,228...30,834,916
|
|
G |
Polr2h-ps1 |
polymerase (RNA) II (DNA directed) polypeptide H, pseudogene 1 |
increases expression |
EXP |
Buspirone results in increased expression of POLR2H-PS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:104,854,977...104,856,390
|
|
G |
Pomc |
proopiomelanocortin |
increases expression multiple interactions |
ISO |
Buspirone results in increased expression of POMC protein Imipramine inhibits the reaction [Buspirone results in increased expression of POMC protein] |
CTD |
PMID:19762159 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Por |
cytochrome p450 oxidoreductase |
increases expression |
EXP |
Buspirone results in increased expression of POR mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Ppa1 |
inorganic pyrophosphatase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of PPA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
EXP |
Buspirone inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA] |
CTD |
PMID:37341015 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppcs |
phosphopantothenoylcysteine synthetase |
increases expression |
EXP |
Buspirone results in increased expression of PPCS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:133,023,077...133,026,899
Ensembl chr 5:133,023,121...133,026,933
|
|
G |
Ppox |
protoporphyrinogen oxidase |
decreases expression |
EXP |
Buspirone results in decreased expression of PPOX mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:83,697,661...83,701,998
Ensembl chr13:83,664,891...83,701,805
|
|
G |
Ppp1r14a |
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
decreases expression |
EXP |
Buspirone results in decreased expression of PPP1R14A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:84,583,127...84,590,743
Ensembl chr 1:84,586,627...84,590,671
|
|
G |
Ppp1r21 |
protein phosphatase 1, regulatory subunit 21 |
decreases expression |
EXP |
Buspirone results in decreased expression of PPP1R21 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:5,901,518...5,970,684
Ensembl chr 6:5,901,518...5,970,684
|
|
G |
Prc1 |
protein regulator of cytokinesis 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of PRC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
|
|
G |
Prdx5 |
peroxiredoxin 5 |
increases expression |
EXP |
Buspirone results in increased expression of PRDX5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
decreases expression |
EXP |
Buspirone results in decreased expression of PRKACA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Prl |
prolactin |
increases secretion multiple interactions increases expression |
ISO EXP |
Buspirone results in increased secretion of PRL protein Pindolol inhibits the reaction [Buspirone results in increased secretion of PRL protein] Buspirone results in increased expression of PRL protein |
CTD |
PMID:18194152 PMID:19762159 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Proser2 |
proline and serine rich 2 |
increases expression |
EXP |
Buspirone results in increased expression of PROSER2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:72,151,961...72,187,524
Ensembl chr17:72,151,872...72,185,825
|
|
G |
Prr13 |
proline rich 13 |
decreases expression |
EXP |
Buspirone results in decreased expression of PRR13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:133,592,511...133,595,817
Ensembl chr 7:133,592,490...133,601,005
|
|
G |
Prss23 |
serine protease 23 |
decreases expression |
EXP |
Buspirone results in decreased expression of PRSS23 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:143,401,396...143,422,091
|
|
G |
Psenen |
presenilin enhancer gamma secretase subunit |
increases expression |
EXP |
Buspirone results in increased expression of PSENEN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:85,814,905...85,816,654
Ensembl chr 1:85,814,905...85,816,192
|
|
G |
Psmb10 |
proteasome 20S subunit beta 10 |
decreases expression |
EXP |
Buspirone results in decreased expression of PSMB10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
|
|
G |
Psmb3 |
proteasome 20S subunit beta 3 |
increases expression |
EXP |
Buspirone results in increased expression of PSMB3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:82,697,425...82,704,521
Ensembl chr10:82,697,425...82,704,521
|
|
G |
Psmb4 |
proteasome 20S subunit beta 4 |
increases expression |
EXP |
Buspirone results in increased expression of PSMB4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:182,442,757...182,445,532
Ensembl chr 2:182,442,756...182,445,746
|
|
G |
Psmb8 |
proteasome 20S subunit beta 8 |
decreases expression |
EXP |
Buspirone results in decreased expression of PSMB8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:4,652,159...4,655,122
Ensembl chr20:4,652,159...4,655,283
|
|
G |
Psmb9 |
proteasome 20S subunit beta 9 |
decreases expression |
EXP |
Buspirone results in decreased expression of PSMB9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
|
|
G |
Ptgr3 |
prostaglandin reductase 3 |
increases expression |
EXP |
Buspirone results in increased expression of PTGR3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:77,454,435...77,463,785
Ensembl chr18:77,454,435...77,463,785
|
|
G |
Ptma |
prothymosin alpha |
decreases expression |
EXP |
Buspirone results in decreased expression of PTMA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
|
|
G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
decreases expression |
EXP |
Buspirone results in decreased expression of PTPRF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:131,741,959...131,824,000
Ensembl chr 5:131,742,754...131,810,023
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
decreases expression |
EXP |
Buspirone results in decreased expression of PTTG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
EXP |
Buspirone inhibits the reaction [Methotrexate results in increased expression of PYCARD protein] |
CTD |
PMID:37341015 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Pygl |
glycogen phosphorylase L |
decreases expression |
EXP |
Buspirone results in decreased expression of PYGL mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
|
|
G |
R3hdm2 |
R3H domain containing 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of R3HDM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:63,212,519...63,340,574
Ensembl chr 7:63,232,346...63,340,540
|
|
G |
Rab17 |
RAB17, member RAS oncogene family |
increases expression |
EXP |
Buspirone results in increased expression of RAB17 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:91,552,924...91,566,759
Ensembl chr 9:91,553,464...91,566,451
|
|
G |
Rab29 |
RAB29, member RAS oncogene family |
increases expression |
EXP |
Buspirone results in increased expression of RAB29 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:43,307,757...43,313,420
Ensembl chr13:43,307,775...43,313,417
|
|
G |
Rab30 |
RAB30, member RAS oncogene family |
increases expression |
EXP |
Buspirone results in increased expression of RAB30 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:146,803,719...146,898,369
Ensembl chr 1:146,803,714...146,892,181
|
|
G |
Rab34 |
RAB34, member RAS oncogene family |
increases expression |
EXP |
Buspirone results in increased expression of RAB34 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:63,083,319...63,087,538
Ensembl chr10:63,083,338...63,087,538
|
|
G |
Rab38 |
RAB38, member RAS oncogene family |
decreases expression |
EXP |
Buspirone results in decreased expression of RAB38 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:142,182,566...142,262,923
Ensembl chr 1:142,182,556...142,262,924
|
|
G |
Rab5if |
RAB5 interacting factor |
increases expression |
EXP |
Buspirone results in increased expression of RAB5IF mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:145,357,990...145,368,012
Ensembl chr 3:145,357,861...145,368,012
|
|
G |
Rab7a |
RAB7A, member RAS oncogene family |
decreases expression |
EXP |
Buspirone results in decreased expression of RAB7A mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:120,461,966...120,510,756
Ensembl chr 4:120,461,963...120,506,889
|
|
G |
Rabac1 |
Rab acceptor 1 |
increases expression |
EXP |
Buspirone results in increased expression of RABAC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:80,564,029...80,567,164
Ensembl chr 1:80,564,033...80,567,163
|
|
G |
Ran |
RAN, member RAS oncogene family |
decreases expression |
EXP |
Buspirone results in decreased expression of RAN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
|
|
G |
Rangap1 |
RAN GTPase activating protein 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of RANGAP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:113,224,695...113,250,441
Ensembl chr 7:113,224,703...113,250,438
|
|
G |
Rapgef4 |
Rap guanine nucleotide exchange factor 4 |
increases expression |
EXP |
Buspirone results in increased expression of RAPGEF4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
|
|
G |
Rarb |
retinoic acid receptor, beta |
decreases expression |
EXP |
Buspirone results in decreased expression of RARB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of RB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbfa |
ribosome binding factor A |
decreases expression |
EXP |
Buspirone results in decreased expression of RBFA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:73,639,264...73,648,914
Ensembl chr18:73,639,260...73,648,915
|
|
G |
Rcan1 |
regulator of calcineurin 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of RCAN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045
|
|
G |
Rcl1 |
RNA terminal phosphate cyclase-like 1 |
increases expression |
EXP |
Buspirone results in increased expression of RCL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:226,824,561...226,869,046
Ensembl chr 1:226,824,534...226,902,315
|
|
G |
Rdh11 |
retinol dehydrogenase 11 |
decreases expression |
EXP |
Buspirone results in decreased expression of RDH11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:97,979,377...97,995,252
Ensembl chr 6:97,979,378...97,995,252
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
Buspirone inhibits the reaction [Methotrexate results in increased expression of RELA mRNA] |
CTD |
PMID:37341015 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Retreg1 |
reticulophagy regulator 1 |
increases expression |
EXP |
Buspirone results in increased expression of RETREG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:76,335,609...76,474,817
Ensembl chr 2:76,335,609...76,493,898
|
|
G |
Rex1bd |
required for excision 1-B domain containing |
increases expression |
EXP |
Buspirone results in increased expression of REX1BD mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:18,922,050...18,924,521
Ensembl chr16:18,922,037...18,924,526
|
|
G |
Rhob |
ras homolog family member B |
decreases expression |
EXP |
Buspirone results in decreased expression of RHOB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
|
|
G |
Rig1 |
RNA sensor RIG-1 |
decreases expression |
EXP |
Buspirone results in decreased expression of RIGI mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
|
|
G |
Rnd2 |
Rho family GTPase 2 |
increases expression |
EXP |
Buspirone results in increased expression of RND2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:86,399,151...86,402,750
Ensembl chr10:86,399,148...86,402,742
|
|
G |
Rnf125 |
ring finger protein 125 |
decreases expression |
EXP |
Buspirone results in decreased expression of RNF125 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:12,254,066...12,275,719
Ensembl chr18:12,253,852...12,275,983
|
|
G |
Rnf139 |
ring finger protein 139 |
increases expression |
EXP |
Buspirone results in increased expression of RNF139 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:90,439,726...90,450,911
Ensembl chr 7:90,436,621...90,488,009
|
|
G |
Rnf149 |
ring finger protein 149 |
increases expression |
EXP |
Buspirone results in increased expression of RNF149 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:41,826,825...41,854,381
Ensembl chr 9:41,830,233...41,854,279
|
|
G |
Rnf26 |
ring finger protein 26 |
decreases expression |
EXP |
Buspirone results in decreased expression of RNF26 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:44,454,551...44,456,745
Ensembl chr 8:44,454,292...44,457,331
|
|
G |
Rorc |
RAR-related orphan receptor C |
decreases expression |
EXP |
Buspirone results in decreased expression of RORC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
G |
Rpa1 |
replication protein A1 |
decreases expression |
EXP |
Buspirone results in decreased expression of RPA1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
|
|
G |
Rpa3 |
replication protein A3 |
decreases expression |
EXP |
Buspirone results in decreased expression of RPA3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:36,304,649...36,307,755
Ensembl chr 4:36,304,651...36,307,709
|
|
G |
Rpe |
ribulose-5-phosphate-3-epimerase |
decreases expression |
EXP |
Buspirone results in decreased expression of RPE mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:68,191,027...68,211,295
Ensembl chr 9:68,191,292...68,211,591
|
|
G |
Rpl7l1 |
ribosomal protein L7-like 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of RPL7L1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:14,198,101...14,206,119
Ensembl chr 9:14,198,092...14,206,110
|
|
G |
Rpn1 |
ribophorin I |
decreases expression |
EXP |
Buspirone results in decreased expression of RPN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:120,543,667...120,565,069
Ensembl chr 4:120,543,667...120,565,069
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
decreases expression |
EXP |
Buspirone results in decreased expression of RRM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
|
|
G |
RT1-Ba |
RT1 class II, locus Ba |
decreases expression |
EXP |
Buspirone results in decreased expression of RT1-BA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
|
|
G |
RT1-Da |
RT1 class II, locus Da |
decreases expression |
EXP |
Buspirone results in decreased expression of RT1-DA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:4,513,464...4,518,457
Ensembl chr20:4,512,911...4,518,455
|
|
G |
RT1-DMb |
RT1 class II, locus DMb |
decreases expression |
EXP |
Buspirone results in decreased expression of HLA-DMB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340
|
|
G |
RT1-S3 |
RT1 class Ib, locus S3 |
decreases expression |
EXP |
Buspirone results in decreased expression of RT1-S3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:2,670,654...2,675,411
Ensembl chr20:2,670,709...2,675,411
|
|
G |
S100b |
S100 calcium binding protein B |
decreases response to substance |
ISO |
S100B results in decreased susceptibility to Buspirone |
CTD |
PMID:12888777 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Sae1 |
SUMO1 activating enzyme subunit 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of SAE1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:77,030,961...77,086,937
Ensembl chr 1:77,030,965...77,086,986
|
|
G |
Sall1 |
spalt-like transcription factor 1 |
increases expression |
EXP |
Buspirone results in increased expression of SALL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr19:18,005,782...18,022,705
Ensembl chr19:18,007,503...18,022,705
|
|
G |
Sar1b |
secretion associated, Ras related GTPase 1B |
increases expression |
EXP |
Buspirone results in increased expression of SAR1B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:36,024,415...36,054,069
Ensembl chr10:36,024,382...36,054,066
|
|
G |
Sarnp |
SAP domain containing ribonucleoprotein |
decreases expression |
EXP |
Buspirone results in decreased expression of SARNP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:1,251,096...1,305,335
Ensembl chr 7:1,251,098...1,305,332
|
|
G |
Sat2 |
spermidine/spermine N1-acetyltransferase family member 2 |
increases expression |
EXP |
Buspirone results in increased expression of SAT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:54,340,756...54,343,507
Ensembl chr10:54,340,372...54,343,224
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of SCARB1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
EXP |
Buspirone results in decreased expression of SCD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scfd1 |
sec1 family domain containing 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of SCFD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:68,795,810...68,874,076
Ensembl chr 6:68,795,878...68,874,078
|
|
G |
Scly |
selenocysteine lyase |
decreases expression |
EXP |
Buspirone results in decreased expression of SCLY mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:91,890,269...91,910,947
Ensembl chr 9:91,890,306...91,910,941
|
|
G |
Sdc4 |
syndecan 4 |
increases expression |
EXP |
Buspirone results in increased expression of SDC4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
|
|
G |
Sdf2 |
stromal cell derived factor 2 |
increases expression |
EXP |
Buspirone results in increased expression of SDF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:63,140,563...63,151,038
Ensembl chr10:63,140,563...63,201,109
|
|
G |
Sds |
serine dehydratase |
increases expression |
EXP |
Buspirone results in increased expression of SDS mRNA |
CTD |
PMID:24136188 |
|
NCBI chr12:36,083,226...36,090,540
Ensembl chr12:36,083,229...36,088,203
|
|
G |
Sec13 |
SEC13 homolog, nuclear pore and COPII coat complex component |
decreases expression |
EXP |
Buspirone results in decreased expression of SEC13 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:146,877,739...146,891,130
Ensembl chr 4:146,875,524...146,891,173
|
|
G |
Sec22b |
SEC22 homolog B, vesicle trafficking protein |
decreases expression |
EXP |
Buspirone results in decreased expression of SEC22B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:185,500,029...185,520,811
Ensembl chr 2:185,500,004...185,522,026
|
|
G |
Sec23b |
Sec23 homolog B, COPII coat complex component |
decreases expression |
EXP |
Buspirone results in decreased expression of SEC23B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:131,939,011...131,981,489
Ensembl chr 3:131,939,337...131,981,489
|
|
G |
Sec61a1 |
SEC61 translocon subunit alpha 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of SEC61A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:120,973,519...120,987,871
Ensembl chr 4:120,960,626...120,987,925
|
|
G |
Sec63 |
SEC63 homolog, protein translocation regulator |
decreases expression |
EXP |
Buspirone results in decreased expression of SEC63 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:46,245,101...46,314,055
Ensembl chr20:46,245,101...46,314,055
|
|
G |
Secisbp2l |
SECIS binding protein 2-like |
decreases expression |
EXP |
Buspirone results in decreased expression of SECISBP2L mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:112,989,613...113,036,060
Ensembl chr 3:112,991,908...113,035,884
|
|
G |
Septin10 |
septin 10 |
decreases expression |
EXP |
Buspirone results in decreased expression of SEPTIN10 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:27,101,764...27,194,997
Ensembl chr20:27,101,752...27,194,780
|
|
G |
Septin7 |
septin 7 |
decreases expression |
EXP |
Buspirone results in decreased expression of SEPTIN7 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:23,719,448...23,783,247
Ensembl chr 8:23,716,030...23,783,243
|
|
G |
Septin9 |
septin 9 |
decreases expression |
EXP |
Buspirone results in decreased expression of SEPTIN9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:102,409,798...102,579,056
Ensembl chr10:102,409,711...102,579,055
|
|
G |
Serpina11 |
serpin family A member 11 |
increases expression |
EXP |
Buspirone results in increased expression of SERPINA11 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:122,903,246...122,912,695
Ensembl chr 6:122,903,250...122,912,670
|
|
G |
Serpina6 |
serpin family A member 6 |
decreases expression |
EXP |
Buspirone results in decreased expression of SERPINA6 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:122,780,043...122,790,349
|
|
G |
Serpinb9 |
serpin family B member 9 |
decreases expression |
EXP |
Buspirone results in decreased expression of SERPINB9 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:31,420,118...31,443,237
Ensembl chr17:31,420,125...31,443,230
|
|
G |
Sf3a3 |
splicing factor 3a, subunit 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of SF3A3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:136,967,713...136,987,345
Ensembl chr 5:136,967,691...136,987,361
|
|
G |
Sfpq |
splicing factor proline and glutamine rich |
decreases expression |
EXP |
Buspirone results in decreased expression of SFPQ mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
|
|
G |
Sft2d2 |
SFT2 domain containing 2 |
increases expression |
EXP |
Buspirone results in increased expression of SFT2D2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:77,484,778...77,504,123
Ensembl chr13:77,484,636...77,504,112
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of SGK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Sgpp1 |
sphingosine-1-phosphate phosphatase 1 |
increases expression |
EXP |
Buspirone results in increased expression of SGPP1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:94,425,339...94,446,534
Ensembl chr 6:94,425,339...94,446,534
|
|
G |
Sh3bgrl3 |
SH3 domain binding glutamate-rich protein like 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of SH3BGRL3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:146,354,152...146,355,525
Ensembl chr 5:146,354,152...146,355,331
|
|
G |
Sh3bp5 |
SH3-domain binding protein 5 |
increases expression |
EXP |
Buspirone results in increased expression of SH3BP5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:6,583,462...6,678,344
Ensembl chr16:6,583,465...6,698,975
|
|
G |
Shmt2 |
serine hydroxymethyltransferase 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of SHMT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:63,358,961...63,364,293
Ensembl chr 7:63,358,961...63,364,236
|
|
G |
Sidt2 |
SID1 transmembrane family, member 2 |
increases expression |
EXP |
Buspirone results in increased expression of SIDT2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:46,232,379...46,248,913
Ensembl chr 8:46,232,383...46,248,700
|
|
G |
Sin3b |
SIN3 transcription regulator family member B |
increases expression |
EXP |
Buspirone results in increased expression of SIN3B mRNA |
CTD |
PMID:24136188 |
|
NCBI chr16:17,123,277...17,159,978
Ensembl chr16:17,123,434...17,159,978
|
|
G |
Sirt5 |
sirtuin 5 |
decreases expression |
EXP |
Buspirone results in decreased expression of SIRT5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:21,310,028...21,337,137
Ensembl chr17:21,310,028...21,337,101
|
|
G |
Slc17a3 |
solute carrier family 17 member 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of SLC17A3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:41,270,804...41,300,132
Ensembl chr17:41,270,812...41,295,256
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Buspirone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc25a17 |
solute carrier family 25 member 17 |
increases expression |
EXP |
Buspirone results in increased expression of SLC25A17 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:112,844,375...112,887,014
Ensembl chr 7:112,844,375...112,925,945
|
|
G |
Slc25a20 |
solute carrier family 25 member 20 |
increases expression |
EXP |
Buspirone results in increased expression of SLC25A20 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
|
|
G |
Slc25a22 |
solute carrier family 25 member 22 |
increases expression |
EXP |
Buspirone results in increased expression of SLC25A22 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:196,528,471...196,536,398
Ensembl chr 1:196,528,472...196,536,331
|
|
G |
Slc26a8 |
solute carrier family 26 member 8 |
increases expression |
EXP |
Buspirone results in increased expression of SLC26A8 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:6,686,206...6,749,478
Ensembl chr20:6,697,723...6,749,478
|
|
G |
Slc27a5 |
solute carrier family 27 member 5 |
increases expression |
EXP |
Buspirone results in increased expression of SLC27A5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:73,616,556...73,627,149
Ensembl chr 1:73,616,564...73,627,172
|
|
G |
Slc28a2 |
solute carrier family 28 member 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of SLC28A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:109,366,996...109,387,702
|
|
G |
Slc34a1 |
solute carrier family 34 member 1 |
increases expression |
EXP |
Buspirone results in increased expression of SLC34A1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:9,218,876...9,233,852
Ensembl chr17:9,218,876...9,233,852
|
|
G |
Slc34a2 |
solute carrier family 34 member 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of SLC34A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436
|
|
G |
Slc35b4 |
solute carrier family 35 member B4 |
decreases expression |
EXP |
Buspirone results in decreased expression of SLC35B4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:62,776,993...62,799,013
Ensembl chr 4:62,776,993...62,799,003
|
|
G |
Slc37a4 |
solute carrier family 37 member 4 |
increases expression |
EXP |
Buspirone results in increased expression of SLC37A4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:44,723,216...44,729,301
Ensembl chr 8:44,723,339...44,729,301
|
|
G |
Slc41a2 |
solute carrier family 41 member 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of SLC41A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:20,383,714...20,491,178
Ensembl chr 7:20,383,757...20,491,166
|
|
G |
Slc49a4 |
solute carrier family 49 member 4 |
increases expression |
EXP |
Buspirone results in increased expression of SLC49A4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:64,995,629...65,068,929
Ensembl chr11:64,995,679...65,068,926
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
increases expression |
EXP |
Buspirone results in increased expression of SLCO1A2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
|
|
G |
Slfn3 |
schlafen family member 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of SLFN3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:68,020,482...68,060,248
Ensembl chr10:68,055,355...68,060,603
|
|
G |
Smim26 |
small integral membrane protein 26 |
increases expression |
EXP |
Buspirone results in increased expression of SMIM26 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 3:131,990,147...131,991,779
Ensembl chr 3:131,990,291...131,992,132
|
|
G |
Smoc1 |
SPARC related modular calcium binding 1 |
increases expression |
EXP |
Buspirone results in increased expression of SMOC1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:100,701,330...100,897,441
Ensembl chr 6:100,701,346...100,862,699
|
|
G |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of SND1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 4:57,095,205...57,494,501
Ensembl chr 4:57,095,208...57,530,843
|
|
G |
Snrnp25 |
small nuclear ribonucleoprotein U11/U12 subunit 25 |
increases expression |
EXP |
Buspirone results in increased expression of SNRNP25 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:15,420,482...15,423,806
Ensembl chr10:15,420,486...15,423,804
|
|
G |
Sod3 |
superoxide dismutase 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of SOD3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
decreases expression |
EXP |
Buspirone results in decreased expression of SPARC mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
|
|
G |
Spart |
spartin |
decreases expression |
EXP |
Buspirone results in decreased expression of SPART mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:139,292,630...139,319,248
Ensembl chr 2:139,292,355...139,319,248
|
|
G |
Spcs2 |
signal peptidase complex subunit 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of SPCS2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:154,163,724...154,183,152
Ensembl chr 1:154,163,724...154,183,186
|
|
G |
Spg21 |
SPG21 abhydrolase domain containing, maspardin |
increases expression |
EXP |
Buspirone results in increased expression of SPG21 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:65,980,992...66,008,537
Ensembl chr 8:65,980,962...66,008,536
|
|
G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
increases expression |
EXP |
Buspirone results in increased expression of SPINK1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642
|
|
G |
Spns1 |
SPNS lysolipid transporter 1, lysophospholipid |
increases expression |
EXP |
Buspirone results in increased expression of SPNS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:180,942,088...180,949,415
Ensembl chr 1:180,942,088...180,949,370
|
|
G |
Sptssa |
serine palmitoyltransferase, small subunit A |
increases expression |
EXP |
Buspirone results in increased expression of SPTSSA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 6:72,144,714...72,156,130
Ensembl chr 6:72,144,714...72,156,214
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of SREBF1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srgn |
serglycin |
decreases expression |
EXP |
Buspirone results in decreased expression of SRGN mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406
|
|
G |
Srp72 |
signal recognition particle 72 |
decreases expression |
EXP |
Buspirone results in decreased expression of SRP72 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:31,168,175...31,195,717
Ensembl chr14:31,168,293...31,195,729
|
|
G |
Srpra |
SRP receptor subunit alpha |
decreases expression |
EXP |
Buspirone results in decreased expression of SRPRA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470
|
|
G |
Srprb |
SRP receptor subunit beta |
decreases expression |
EXP |
Buspirone results in decreased expression of SRPRB mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:103,768,685...103,782,632
|
|
G |
Srrm2 |
serine/arginine repetitive matrix 2 |
increases expression |
EXP |
Buspirone results in increased expression of SRRM2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:12,815,471...12,848,750
Ensembl chr10:12,815,471...12,848,751
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of SRSF2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
|
|
G |
Srsf3 |
serine and arginine rich splicing factor 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of SRSF3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078
|
|
G |
Srsf4 |
serine and arginine rich splicing factor 4 |
increases expression |
EXP |
Buspirone results in increased expression of SRSF4 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:144,060,981...144,090,798
Ensembl chr 5:144,061,463...144,089,229
|
|
G |
Ssr1 |
signal sequence receptor subunit 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of SSR1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr17:26,833,720...26,861,821
Ensembl chr17:26,833,741...26,861,821
|
|
G |
Ssx2ip |
SSX family member 2 interacting protein |
decreases expression |
EXP |
Buspirone results in decreased expression of SSX2IP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:235,298,012...235,330,750
Ensembl chr 2:235,298,088...235,330,745
|
|
G |
St6gal1 |
ST6 beta-galactoside alpha-2,6-sialyltransferase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of ST6GAL1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310
|
|
G |
Stac3 |
SH3 and cysteine rich domain 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of STAC3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:63,343,078...63,350,590
Ensembl chr 7:63,343,186...63,350,589
|
|
G |
Stap2 |
signal transducing adaptor family member 2 |
increases expression |
EXP |
Buspirone results in increased expression of STAP2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:828,369...838,648
Ensembl chr 9:828,372...837,219
|
|
G |
Stard5 |
StAR-related lipid transfer domain containing 5 |
decreases expression |
EXP |
Buspirone results in decreased expression of STARD5 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:137,606,151...137,616,017
Ensembl chr 1:137,606,177...137,616,469
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of STAT1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stbd1 |
starch binding domain 1 |
increases expression |
EXP |
Buspirone results in increased expression of STBD1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr14:15,470,452...15,473,857
Ensembl chr14:15,469,582...15,477,443
|
|
G |
Steap3 |
STEAP3 metalloreductase |
decreases expression |
EXP |
Buspirone results in decreased expression of STEAP3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:31,351,954...31,397,344
Ensembl chr13:31,351,954...31,396,519
|
|
G |
Stmn1 |
stathmin 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of STMN1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Sumo3 |
small ubiquitin-like modifier 3 |
decreases expression |
EXP |
Buspirone results in decreased expression of SUMO3 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr20:11,010,140...11,020,850
Ensembl chr20:11,007,148...11,020,877 Ensembl chr20:11,007,148...11,020,877
|
|
G |
Sun2 |
Sad1 and UNC84 domain containing 2 |
increases expression |
EXP |
Buspirone results in increased expression of SUN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 7:111,275,374...111,292,565
Ensembl chr 7:111,275,380...111,292,553
|
|
G |
Svip |
small VCP interacting protein |
increases expression |
EXP |
Buspirone results in increased expression of SVIP mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:101,587,128...101,592,818
Ensembl chr 1:101,587,128...101,593,116
|
|
G |
Tagln2 |
transgelin 2 |
decreases expression |
EXP |
Buspirone results in decreased expression of TAGLN2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
|
|
G |
Tars1 |
threonyl-tRNA synthetase 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of TARS1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:60,368,893...60,387,715
Ensembl chr 2:60,367,796...60,387,717
|
|
G |
Tcerg1 |
transcription elongation regulator 1 |
decreases expression |
EXP |
Buspirone results in decreased expression of TCERG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr18:34,505,708...34,566,470
Ensembl chr18:34,505,751...34,566,470
|
|
G |
Tcirg1 |
T-cell immune regulator 1, ATPase H+ transporting V0 subunit A3 |
decreases expression |
EXP |
Buspirone results in decreased expression of TCIRG1 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 1:201,127,034...201,138,787
Ensembl chr 1:201,127,034...201,138,742
|
|
G |
Tcta |
T-cell leukemia translocation altered |
increases expression |
EXP |
Buspirone results in increased expression of TCTA mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 8:108,988,588...108,992,324
Ensembl chr 8:108,988,590...108,991,564
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
increases expression |
EXP |
Buspirone results in increased expression of TDO2 mRNA |
CTD |
PMID:24136188 |
|
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
G |
Tef |
TEF transcription factor, PAR bZIP family member |
increases expression |
| |